Ask a research question about Primary_Ciliary_Dyskinesia. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Primary_Ciliary_Dyskinesia
creation_date: '2025-12-04T16:57:31Z'
updated_date: '2026-04-28T12:00:00Z'
category: Genetic
parents:
- Ciliopathy
- Respiratory Disease
prevalence:
- population: Europe
subtype: Prevalence at birth
percentage: 0.001-0.01
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "1-9 / 100 000 | Europe | Prevalence at birth | PMID:23871404"
explanation: Orphanet epidemiology data reports prevalence at birth in Europe of 1-9 per 100,000.
- reference: PMID:23871404
supports: SUPPORT
snippet: "Prevalence, about 1/15,000 to 1/30,000, is probably underestimated, as diagnosis might not be evocated in absence of Kartagener syndrome."
explanation: French review estimates prevalence at 1/15,000 to 1/30,000, consistent with the Orphanet range of 1-9 per 100,000.
- population: Pakistan (British Asian)
subtype: Point prevalence
percentage: 0.01-0.05
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "1-5 / 10 000 | Pakistan | Point prevalence | PMID:19720631"
explanation: Orphanet epidemiology data reports point prevalence in Pakistan of 1-5 per 10,000.
- reference: PMID:19720631
supports: SUPPORT
snippet: "The prevalence of PCD in the population studied was one in 2265."
explanation: High prevalence in a consanguineous British Asian population from Bradford, UK, consistent with the Orphanet range.
pathophysiology:
- name: Ciliary Dysfunction
conforms_to: "ciliopathy_dysfunction#Motile Cilia Beat Dysfunction"
description: Defects in the structure and function of motile cilia impair mucociliary clearance.
genes:
- preferred_term: DNAI1
term:
id: hgnc:2954
label: DNAI1
- preferred_term: DNAH5
term:
id: hgnc:2950
label: DNAH5
cell_types:
- preferred_term: respiratory ciliated cell
term:
id: CL:0002368
label: respiratory tract epithelial cell
- preferred_term: ependymal cell
term:
id: CL:0000065
label: ependymal cell
biological_processes:
- preferred_term: cilium movement
term:
id: GO:0003341
label: cilium movement
- preferred_term: cilium assembly
term:
id: GO:0060271
label: cilium assembly
- preferred_term: axoneme assembly
term:
id: GO:0035082
label: axoneme assembly
locations:
- preferred_term: respiratory tract epithelium
term:
id: UBERON:0004802
label: respiratory tract epithelium
- preferred_term: nasal cavity epithelium
term:
id: UBERON:0005384
label: nasal cavity epithelium
- preferred_term: trachea
term:
id: UBERON:0003126
label: trachea
- preferred_term: bronchus
term:
id: UBERON:0002185
label: bronchus
cellular_components:
- preferred_term: Cilia
term:
id: GO:0005929
label: cilium
- preferred_term: axoneme
term:
id: GO:0005930
label: axoneme
- preferred_term: outer dynein arm
term:
id: GO:0036157
label: outer dynein arm
downstream:
- target: Impaired Mucociliary Clearance
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "A rare, genetically heterogeneous, primarily respiratory disorder characterized by chronic upper and lower respiratory tract disease."
explanation: Orphanet definition confirms PCD is characterized by ciliary dysfunction leading to chronic respiratory disease.
- reference: PMID:19818430
reference_title: "[Primary ciliary dyskinesia. Ciliopathies]."
supports: SUPPORT
snippet: Primary ciliary dyskinesia is a genetically inherited syndrome characterized by cilia immotility or dysmotility. Deficiency in mucociliary clearance produces chronic respiratory infections since birth.
explanation: The reference confirms that defects in the structure and function of motile cilia impair mucociliary clearance, supporting the statement.
- reference: PMID:20525503
reference_title: "Cilia dysfunction."
supports: SUPPORT
snippet: Ciliary dysfunction may be primary, the result of genetic mutations resulting in abnormal cilia structure, or secondary, the result of environmental, infectious or inflammatory stimuli that disrupt normal motility or coordination.
explanation: This reference supports the statement by indicating that primary ciliary dyskinesia results from genetic mutations affecting cilia structure and function, leading to impaired mucociliary clearance.
- reference: PMID:17059358
reference_title: "Genetic defects in ciliary structure and function."
supports: SUPPORT
snippet: The most prominent genetic abnormality involving motile cilia (and the respiratory tract) is primary ciliary dyskinesia (PCD). PCD is a rare, usually autosomal recessive, genetically heterogeneous disorder characterized by sino-pulmonary disease, laterality defects, and male infertility.
explanation: The reference supports the statement by describing PCD as a disorder involving motile cilia defects, which leads to respiratory issues due to impaired mucociliary clearance.
- reference: PMID:15750039
reference_title: "Mislocalization of DNAH5 and DNAH9 in respiratory cells from patients with primary ciliary dyskinesia."
supports: SUPPORT
snippet: Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder characterized by recurrent infections of the airways and situs inversus in half of the affected offspring. The most frequent genetic defects comprise recessive mutations of DNAH5 and DNAI1, which encode outer dynein arm (ODA) components.
explanation: This reference supports the statement by listing DNAH5 and DNAI1 as genes involved in PCD, which is characterized by defects in motile cilia leading to impaired mucociliary clearance.
- reference: PMID:32185794
reference_title: "A nonsense variant in NME5 causes human primary ciliary dyskinesia with radial spoke defects."
supports: SUPPORT
snippet: Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder characterized by defects in the function or structure of motitle cilia
explanation: The reference supports the statement by confirming that PCD involves defects in the structure and function of motile cilia, which impair mucociliary clearance.
- name: Impaired Mucociliary Clearance
description: Failure to effectively remove mucus and pathogens from respiratory passages.
biological_processes:
- preferred_term: mucociliary clearance
term:
id: GO:0120197
label: mucociliary clearance
locations:
- preferred_term: respiratory system
term:
id: UBERON:0001004
label: respiratory system
- preferred_term: paranasal sinus
term:
id: UBERON:0001825
label: paranasal sinus
downstream:
- target: Chronic Respiratory Infections
- target: Sinusitis
- target: Otitis Media
evidence:
- reference: PMID:11376511
reference_title: "Pathophysiology and treatment of airway mucociliary clearance. A moving tale."
supports: SUPPORT
snippet: Failure to keep the airways sterile by MCC results in a host inflammatory response to the persistent microorganisms which, if it becomes chronic, causes damage to the airway wall and upregulation of mucus production manifest clinically as bronchiectasis, sinusitis and otitis.
explanation: The literature supports that primary ciliary dyskinesia (PCD) leads to impaired mucociliary clearance, which results in chronic respiratory infections, sinusitis, and otitis media.
- reference: PMID:17142159
reference_title: "Primary ciliary dyskinesia and newborn respiratory distress."
supports: SUPPORT
snippet: Primary ciliary dyskinesia is an autosomal recessive genetic disease that results in impaired mucociliary clearance causing progressive involvement of the upper and lower respiratory tract, characterized by airway obstruction and recurrent infections of the lungs, middle ear and paranasal sinuses.
explanation: The literature supports that primary ciliary dyskinesia leads to impaired mucociliary clearance and downstream chronic respiratory infections, sinusitis, and otitis media.
- reference: PMID:15917207
reference_title: "Cilia and disease."
supports: SUPPORT
snippet: Disruption of 9+2 cilia, which move mucus across respiratory epithelia, leads to rhinitis, sinusitis and bronchiectasis.
explanation: The literature supports that disruption of motile cilia, as seen in primary ciliary dyskinesia, leads to impaired mucociliary clearance and resultant respiratory conditions such as sinusitis and bronchiectasis.
- reference: PMID:29490941
reference_title: "Olfactory dysfunction is worse in primary ciliary dyskinesia compared with other causes of chronic sinusitis in children."
supports: SUPPORT
snippet: We hypothesised that olfactory function could be impaired in primary ciliary dyskinesia (PCD). Olfaction, nasal nitric oxide (nNO) and sinus CT were assessed in patients with PCD and non-PCD sinus disease, and healthy controls (no CT scan). PCD and non-PCD patients had similar severity of sinus disease.
explanation: The literature supports that primary ciliary dyskinesia leads to impaired mucociliary clearance and associated conditions such as sinusitis.
- name: Situs Inversus
description: Abnormal placement of internal organs due to ciliary dysfunction during embryonic development.
frequency: 50%
biological_processes:
- preferred_term: determination of left/right symmetry
term:
id: GO:0007368
label: determination of left/right symmetry
- preferred_term: nodal cilium assembly
term:
id: GO:0044458
label: motile cilium assembly
locations:
- preferred_term: embryo
term:
id: UBERON:0000922
label: embryo
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "Approximately half of the patients have an organ laterality defect (situs inversus totalis or situs ambiguus/heterotaxy)."
explanation: Orphanet definition confirms that approximately half of PCD patients have laterality defects.
- reference: PMID:16036877
reference_title: "Primary ciliary dyskinesia: a review."
supports: PARTIAL
snippet: The normal left-right asymmetry of the body is thought to be due to the beating of the cilia in the embryonic (Hensen's) node. Total immotility of the cilia should therefore result in random asymmetry of the body that is situs inversus in 50% of the cases. It has also been claimed that 50% of cases with PCD have situs inversus.
explanation: The statement is partially supported. The literature confirms that primary ciliary dyskinesia (PCD) can lead to situs inversus due to ciliary dysfunction during embryonic development, and it is claimed that 50% of PCD cases have situs inversus. However, the phrase 'abnormal placement of internal organs' is more general and could include other forms of laterality defects, not just situs inversus.
- reference: PMID:36342963
reference_title: "Laterality Defects in Primary Ciliary Dyskinesia: Relationship to Ultrastructural Defect or Genotype."
supports: PARTIAL
snippet: 'Results: Of 559 participants, 286 (51.2%), 215 (38.5%), and 58 (10.4%) were identified as having situs solitus, situs inversustotalis, and situs ambiguus, respectively; heterotaxy, defined as situs ambiguus with complex cardiovascular defects, was present in 14 (2.5%)'
explanation: The statement is partially supported. The data shows that 38.5% of PCD cases have situs inversus totalis, which is close to but not exactly 50%. Additionally, there are other laterality defects like situs ambiguus, which are not covered by the statement.
phenotypes:
- category: Respiratory
name: Chronic Cough
frequency: VERY_FREQUENT
diagnostic: true
evidence:
- reference: PMID:27258773
reference_title: "Toward an Earlier Diagnosis of Primary Ciliary Dyskinesia. Which Patients Should Undergo Detailed Diagnostic Testing?"
supports: SUPPORT
snippet: Primary ciliary dyskinesia (PCD) is a rare, heterogeneous, recessive, genetic disorder of motile cilia, leading to chronic upper and lower respiratory symptoms.
explanation: The statement is supported because PCD leads to chronic respiratory symptoms, including chronic cough.
- reference: PMID:17142159
reference_title: "Primary ciliary dyskinesia and newborn respiratory distress."
supports: SUPPORT
snippet: Primary ciliary dyskinesia is an autosomal recessive genetic disease that results in impaired mucociliary clearance causing progressive involvement of the upper and lower respiratory tract, characterized by airway obstruction and recurrent infections of the lungs, middle ear and paranasal sinuses.
explanation: The statement is supported because PCD causes progressive involvement of the respiratory tract, which includes chronic cough.
phenotype_term:
preferred_term: Chronic Cough
term:
id: HP:0034315
label: Chronic cough
- category: Respiratory
name: Recurrent Respiratory Infections
frequency: VERY_FREQUENT
evidence:
- reference: PMID:39069333
reference_title: "Respiratory Aspects of Primary Ciliary Dyskinesia."
supports: SUPPORT
snippet: This review article explores the respiratory aspects of primary ciliary dyskinesia (PCD), a rare, heterogenous, genetic disorder characterized by impaired motile ciliary function. It discusses the clinical diagnosis and management strategies for PCD-related respiratory disease, including chronic sinusitis, otitis media with effusion, recurrent pneumonia, and bronchiectasis.
explanation: The article discusses recurrent respiratory diseases as a significant aspect of PCD, supporting the statement that recurrent respiratory infections are very frequent in PCD.
- reference: PMID:36214320
reference_title: "In vitro measurement of ciliary beat frequency in 92 children with recurrent respiratory tract problems."
supports: SUPPORT
snippet: 'Ninety-two children with chronic respiratory symptoms were divided into 4 groups: 18 children with refractory asthma, 10 with bronchiectasis without dextrocardia, 18 with dextrocardia and 46 with recurrent respiratory tract infections.'
explanation: The study highlights recurrent respiratory tract infections in children with chronic respiratory symptoms, supporting the statement that recurrent respiratory infections are very frequent in PCD.
- reference: PMID:31430425
reference_title: "Prevalence of chronic rhinosinusitis in bronchiectasis patients suspected of ciliary dyskinesia."
supports: SUPPORT
snippet: The objective of this study was to evaluate the prevalence of chronic rhinosinusitis (CRS) and its characteristics in bronchiectasis patients suspected of harboring ciliary dyskinesia.
explanation: The study mentions chronic rhinosinusitis and bronchiectasis in patients suspected of ciliary dyskinesia, indicating frequent respiratory issues.
- reference: PMID:25370419
reference_title: "Simultaneous sinus and lung infections in patients with primary ciliary dyskinesia."
supports: SUPPORT
snippet: The sinuses should be considered as a bacterial reservoir and a target for surgery and antibiotic treatment in patients with primary ciliary dyskinesia (PCD).
explanation: The study discusses sinus infections as a common issue in PCD, supporting the statement about frequent respiratory infections.
phenotype_term:
preferred_term: Recurrent Respiratory Infections
term:
id: HP:0002205
label: Recurrent respiratory infections
- category: Respiratory
name: Bronchiectasis
frequency: FREQUENT
evidence:
- reference: ORPHA:244
supports: PARTIAL
snippet: "HP:0002110 | Bronchiectasis | Occasional (29-5%)"
explanation: Orphanet classifies bronchiectasis as occasional (29-5%), likely reflecting cross-sectional point prevalence rather than cumulative incidence; multiple PMIDs describe it as a defining long-term complication of PCD.
- reference: PMID:10894096
reference_title: "Ciliary assessment in bronchiectasis."
supports: SUPPORT
snippet: Patients with primary ciliary dyskinesia could potentially develop recurrent sinotrachrobronchitis, bronchiectasis, serous otitis media, hydrocephalus, and male infertility.
explanation: The article mentions bronchiectasis as one of the potential conditions that patients with PCD could develop.
- reference: PMID:36344229
reference_title: "[Sinusitis, otitis media and diffuse bronchiectasis in both lungs]."
supports: SUPPORT
snippet: Typical manifestations include bronchiectasis, secretory otitis media, sinusitis, situs inversus, and infertility.
explanation: The article lists bronchiectasis as a typical manifestation of primary ciliary dyskinesia.
- reference: PMID:25673230
reference_title: "Lung structure-function correlation in patients with primary ciliary dyskinesia."
supports: SUPPORT
snippet: Primary ciliary dyskinesia (PCD) is a rare disease, characterised by chronic airway infection.
explanation: The article discusses the relationship between functional and structural abnormalities in PCD, including bronchiectasis.
- reference: PMID:21680564
reference_title: "Cystic fibrosis, primary ciliary dyskinesia and non-cystic fibrosis bronchiectasis: update 2008-11."
supports: SUPPORT
snippet: A review is presented of key clinical papers published in Thorax and elsewhere between 2008 and April 2011 which have advanced our understanding of cystic fibrosis (CF), primary ciliary dyskinesia and non-CF bronchiectasis.
explanation: The article discusses primary ciliary dyskinesia and non-CF bronchiectasis, implying a connection between PCD and bronchiectasis.
- reference: PMID:31430425
reference_title: "Prevalence of chronic rhinosinusitis in bronchiectasis patients suspected of ciliary dyskinesia."
supports: SUPPORT
snippet: The objective of this study was to evaluate the prevalence of chronic rhinosinusitis (CRS) and its characteristics in bronchiectasis patients suspected of harboring ciliary dyskinesia.
explanation: The study evaluates bronchiectasis in patients suspected of having ciliary dyskinesia, indicating a frequent association.
- reference: PMID:37278553
reference_title: "Primary ciliary dyskinesia as a common cause of bronchiectasis in the Canadian Inuit population."
supports: SUPPORT
snippet: Primary ciliary dyskinesia as a common cause of bronchiectasis in the Canadian Inuit population.
explanation: The article explicitly states that PCD is a common cause of bronchiectasis in a specific population.
- reference: PMID:33895745
reference_title: "The Primary Ciliary Dyskinesia Computed Tomography Score in Adults with Bronchiectasis: A Derivation und Validation Study."
supports: SUPPORT
snippet: Primary ciliary dyskinesia (PCD) is a rare genetic disorder which requires a complex diagnostic workup. Thus, an easy and widely available screening method would be helpful to identify patients who need a further diagnostic workup for PCD.
explanation: The article discusses the need for diagnostic workup for PCD in patients with bronchiectasis, indicating a frequent association.
- reference: PMID:23181248
reference_title: "Congenital problems of mucociliary clearance: primary ciliary dyskinesia."
supports: SUPPORT
snippet: Mucociliary clearance is a primary defence mechanism of the airway that can be altered in congenital diseases such as primary ciliary dyskinesia and cystic fibrosis, as well as acquired conditions.
explanation: The article focuses on primary ciliary dyskinesia and its impact on mucociliary clearance, which is related to bronchiectasis.
- reference: PMID:37852905
reference_title: "Bardet-Biedl Syndrome: An Uncommon Cause of Bronchiectasis."
supports: NO_EVIDENCE
snippet: 'Bardet-Biedl Syndrome: An Uncommon Cause of Bronchiectasis.'
explanation: The article discusses Bardet-Biedl Syndrome as a cause of bronchiectasis, not primary ciliary dyskinesia.
phenotype_term:
preferred_term: Bronchiectasis
term:
id: HP:0002110
label: Bronchiectasis
- category: Otologic
name: Chronic Otitis Media
frequency: FREQUENT
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0000389 | Chronic otitis media | Frequent (79-30%)"
explanation: Orphanet phenotype data classifies chronic otitis media as frequent (79-30%) in primary ciliary dyskinesia.
- reference: PMID:29135867
reference_title: "Analysis of Otologic Features of Patients With Primary Ciliary Dyskinesia."
supports: SUPPORT
snippet: All 15 patients showed ciliary ultrastructural abnormalities on electron microscopy and/or biallelic mutations in genes associated with ciliary function or structure. All 30 eardrums examined showed certain abnormalities. Fourteen patients had otitis media with effusion or its sequelae. The remaining patient had chronic otitis media.
explanation: The study found that patients with primary ciliary dyskinesia (PCD) frequently exhibited otologic issues, including chronic otitis media.
- reference: PMID:19796826
reference_title: "Management of otitis media with effusion in children with primary ciliary dyskinesia: a literature review."
supports: SUPPORT
snippet: Primary ciliary dyskinesia is an autosomal recessively inherited group of disorders of ciliary ultrastructure. Otolaryngologists are frequently involved in the management of some of the most common symptoms of primary ciliary dyskinesia including chronic rhinitis, sinusitis and otitis media with effusion.
explanation: This reference supports that chronic otitis media and other otologic issues are common in patients with primary ciliary dyskinesia.
phenotype_term:
preferred_term: Chronic Otitis Media
term:
id: HP:0000389
label: Chronic otitis media
- category: Otologic
name: Hearing Loss
frequency: OCCASIONAL
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0000365 | Hearing impairment | Occasional (29-5%)"
explanation: Orphanet phenotype data classifies hearing impairment as occasional (29-5%) in primary ciliary dyskinesia.
- reference: PMID:29287859
reference_title: "Hearing loss in children with primary ciliary dyskinesia."
supports: REFUTE
snippet: Slight to mild CHL and all types of otitis media are prevalent among patients with PCD, and some of these children have sensorineural hearing loss (SNHL).
explanation: The study indicates that hearing loss is a prevalent condition among patients with primary ciliary dyskinesia (PCD), not occasional.
- reference: PMID:9222635
reference_title: "Otological manifestations of primary ciliary dyskinesia."
supports: REFUTE
snippet: All children (11 patients) had bilateral otitis media with effusion. Of the five adults, three had tympanosclerosis; one had bilateral cholesteatoma; and one patient had bilateral keratosis obturans in combination with tympanosclerosis.
explanation: The study describes otological manifestations including hearing loss as a prominent feature in patients with PCD, suggesting it is not occasional but rather common.
- reference: PMID:33844744
reference_title: "Observed Frequency and Characteristics of Hearing Loss in Osteogenesis Imperfecta."
supports: NO_EVIDENCE
snippet: In this group of patients with OI, 30% had hearing loss and among those ears with normal hearing, 13% did not have an acoustic stapedial reflex.
explanation: This study discusses hearing loss in osteogenesis imperfecta (OI), not primary ciliary dyskinesia (PCD).
phenotype_term:
preferred_term: Hearing Loss
term:
id: HP:0000365
label: Hearing impairment
- category: Otorhinolaryngologic
name: Nasal Polyposis
phenotype_term:
preferred_term: Nasal Polyposis
term:
id: HP:0100582
label: Nasal polyposis
frequency: FREQUENT
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0100582 | Nasal polyposis | Frequent (79-30%)"
explanation: Orphanet phenotype data classifies nasal polyposis as frequent (79-30%) in primary ciliary dyskinesia.
- reference: PMID:37997295
reference_title: "Histologic characterization of primary ciliary dyskinesia chronic rhinosinusitis."
supports: NO_EVIDENCE
snippet: Despite endoscopic differences, PCD-CRS and cystic fibrosis-related chronic rhinosinusitis (CF-CRS) had similar structured histopathology reports. Compared to healthy patients and those with idiopathic chronic rhinosinusitis without nasal polyps, patients with PCD-CRS had an increased neutrophil count.
explanation: The abstract discusses histopathology and neutrophil count in PCD-CRS, but does not provide evidence on the frequency of nasal polyps in PCD.
- reference: PMID:39069333
reference_title: "Respiratory Aspects of Primary Ciliary Dyskinesia."
supports: NO_EVIDENCE
snippet: This review article explores the respiratory aspects of primary ciliary dyskinesia (PCD), a rare, heterogenous, genetic disorder characterized by impaired motile ciliary function. It discusses the clinical diagnosis and management strategies for PCD-related respiratory disease, including chronic sinusitis, otitis media with effusion, recurrent pneumonia, and bronchiectasis.
explanation: The review focuses on respiratory aspects of PCD and does not mention nasal polyps as a frequent gastrointestinal manifestation.
- category: Cardiac
name: Situs Inversus Totalis
frequency: FREQUENT
evidence:
- reference: ORPHA:244
supports: PARTIAL
snippet: "HP:0001696 | Situs inversus totalis | Occasional (29-5%)"
explanation: Orphanet classifies situs inversus totalis as occasional (29-5%), but literature data shows ~38-50% prevalence, supporting FREQUENT.
- reference: PMID:16036877
reference_title: "Primary ciliary dyskinesia: a review."
supports: PARTIAL
snippet: Total immotility of the cilia should therefore result in random asymmetry of the body that is situs inversus in 50% of the cases. It has also been claimed that 50% of cases with PCD have situs inversus.
explanation: The literature indicates that situs inversus, including situs inversus totalis, occurs in approximately 50% of primary ciliary dyskinesia (PCD) cases. This suggests that it is not merely 'occasional' but rather relatively common in PCD patients.
- reference: PMID:36342963
reference_title: "Laterality Defects in Primary Ciliary Dyskinesia: Relationship to Ultrastructural Defect or Genotype."
supports: PARTIAL
snippet: 'Results: Of 559 participants, 286 (51.2%), 215 (38.5%), and 58 (10.4%) were identified as having situs solitus, situs inversustotalis, and situs ambiguus, respectively; heterotaxy, defined as situs ambiguus with complex cardiovascular defects, was present in 14 (2.5%)'
explanation: The data indicates that situs inversus totalis occurs in 38.5% of PCD cases, which is more frequent than 'occasional.'
- reference: PMID:38072392
reference_title: "Situs Ambiguus Is Associated With Adverse Clinical Outcomes in Children With Primary Ciliary Dyskinesia."
supports: PARTIAL
snippet: The remaining 355 participants did not have SA, including 152 with SIT and 203 with SS.
explanation: Situs inversus totalis (SIT) is present in a significant portion of PCD cases, indicating it is more common than 'occasional.'
phenotype_term:
preferred_term: Situs Inversus Totalis
term:
id: HP:0001696
label: Situs inversus totalis
- category: Respiratory
name: Chronic Respiratory Infections
frequency: FREQUENT
phenotype_term:
preferred_term: Chronic Respiratory Infections
term:
id: HP:0002205
label: Recurrent respiratory infections
- category: Respiratory
name: Sinusitis
frequency: FREQUENT
phenotype_term:
preferred_term: Sinusitis
term:
id: HP:0000246
label: Sinusitis
- category: Otologic
name: Otitis Media
frequency: FREQUENT
phenotype_term:
preferred_term: Otitis Media
term:
id: HP:0000388
label: Otitis media
- category: Respiratory
name: Neonatal Respiratory Distress
frequency: FREQUENT
notes: Common presenting feature in newborns with PCD
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0002643 | Neonatal respiratory distress | Frequent (79-30%)"
explanation: Orphanet phenotype data classifies neonatal respiratory distress as frequent (79-30%) in primary ciliary dyskinesia.
- reference: PMID:19720631
supports: SUPPORT
snippet: "73% had a history of neonatal respiratory distress."
explanation: In a consanguineous British Asian PCD cohort, 73% of patients had neonatal respiratory distress.
phenotype_term:
preferred_term: Neonatal respiratory distress
term:
id: HP:0002643
label: Neonatal respiratory distress
- category: Reproductive
name: Male Infertility
frequency: FREQUENT
notes: Due to sperm flagellar defects affecting motility
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0003251 | Male infertility | Frequent (79-30%)"
explanation: Orphanet phenotype data classifies male infertility as frequent (79-30%) in primary ciliary dyskinesia.
phenotype_term:
preferred_term: Male infertility
term:
id: HP:0003251
label: Male infertility
- category: Respiratory
name: Chronic Rhinosinusitis
frequency: FREQUENT
notes: Chronic inflammation of nasal passages and sinuses
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0011109 | Chronic sinusitis | Frequent (79-30%)"
explanation: Orphanet phenotype data classifies chronic sinusitis as frequent (79-30%) in primary ciliary dyskinesia.
phenotype_term:
preferred_term: Chronic rhinosinusitis
term:
id: HP:0011109
label: Chronic sinusitis
- category: Respiratory
name: Productive Cough
frequency: FREQUENT
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0031245 | Productive cough | Frequent (79-30%)"
explanation: Orphanet phenotype data classifies productive cough as frequent (79-30%) in primary ciliary dyskinesia.
phenotype_term:
preferred_term: Productive cough
term:
id: HP:0031245
label: Productive cough
- category: Respiratory
name: Recurrent Sinopulmonary Infections
frequency: FREQUENT
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0005425 | Recurrent sinopulmonary infections | Frequent (79-30%)"
explanation: Orphanet phenotype data classifies recurrent sinopulmonary infections as frequent (79-30%) in primary ciliary dyskinesia.
phenotype_term:
preferred_term: Recurrent sinopulmonary infections
term:
id: HP:0005425
label: Recurrent sinopulmonary infections
- category: Respiratory
name: Nasal Congestion
frequency: FREQUENT
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0001742 | Nasal congestion | Frequent (79-30%)"
explanation: Orphanet phenotype data classifies nasal congestion as frequent (79-30%) in primary ciliary dyskinesia.
phenotype_term:
preferred_term: Nasal congestion
term:
id: HP:0001742
label: Nasal congestion
- category: Respiratory
name: Chronic Rhinitis
frequency: FREQUENT
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0002257 | Chronic rhinitis | Frequent (79-30%)"
explanation: Orphanet phenotype data classifies chronic rhinitis as frequent (79-30%) in primary ciliary dyskinesia.
phenotype_term:
preferred_term: Chronic rhinitis
term:
id: HP:0002257
label: Chronic rhinitis
- category: Respiratory
name: Abnormal Sputum
frequency: FREQUENT
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0032016 | Abnormal sputum | Frequent (79-30%)"
explanation: Orphanet phenotype data classifies abnormal sputum as frequent (79-30%) in primary ciliary dyskinesia.
phenotype_term:
preferred_term: Abnormal sputum
term:
id: HP:0032016
label: Abnormal sputum
- category: Reproductive
name: Abnormal Sperm Motility
frequency: FREQUENT
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0012206 | Abnormal sperm motility | Frequent (79-30%)"
explanation: Orphanet phenotype data classifies abnormal sperm motility as frequent (79-30%) in primary ciliary dyskinesia.
phenotype_term:
preferred_term: Abnormal sperm motility
term:
id: HP:0012206
label: Abnormal sperm motility
- category: Otologic
name: Recurrent Otitis Media
frequency: FREQUENT
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0000403 | Recurrent otitis media | Frequent (79-30%)"
explanation: Orphanet phenotype data classifies recurrent otitis media as frequent (79-30%) in primary ciliary dyskinesia.
phenotype_term:
preferred_term: Recurrent otitis media
term:
id: HP:0000403
label: Recurrent otitis media
- category: Respiratory
name: Wheezing
frequency: OCCASIONAL
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0030828 | Wheezing | Occasional (29-5%)"
explanation: Orphanet phenotype data classifies wheezing as occasional (29-5%) in primary ciliary dyskinesia.
phenotype_term:
preferred_term: Wheezing
term:
id: HP:0030828
label: Wheezing
- category: Reproductive
name: Female Infertility
frequency: OCCASIONAL
notes: Due to impaired ciliary function in fallopian tubes
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0008222 | Female infertility | Occasional (29-5%)"
explanation: Orphanet phenotype data classifies female infertility as occasional (29-5%) in primary ciliary dyskinesia.
phenotype_term:
preferred_term: Female infertility
term:
id: HP:0008222
label: Female infertility
- category: Respiratory
name: Atelectasis
frequency: OCCASIONAL
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0100750 | Atelectasis | Occasional (29-5%)"
explanation: Orphanet phenotype data classifies atelectasis as occasional (29-5%) in primary ciliary dyskinesia.
phenotype_term:
preferred_term: Atelectasis
term:
id: HP:0100750
label: Atelectasis
- category: Otologic
name: Conductive Hearing Impairment
frequency: OCCASIONAL
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0000405 | Conductive hearing impairment | Occasional (29-5%)"
explanation: Orphanet phenotype data classifies conductive hearing impairment as occasional (29-5%) in primary ciliary dyskinesia.
phenotype_term:
preferred_term: Conductive hearing impairment
term:
id: HP:0000405
label: Conductive hearing impairment
- category: Respiratory
name: Airway Obstruction
frequency: OCCASIONAL
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0006536 | Airway obstruction | Occasional (29-5%)"
explanation: Orphanet phenotype data classifies airway obstruction as occasional (29-5%) in primary ciliary dyskinesia.
phenotype_term:
preferred_term: Airway obstruction
term:
id: HP:0006536
label: Airway obstruction
- category: Respiratory
name: Digital Clubbing
frequency: OCCASIONAL
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0001217 | Clubbing | Occasional (29-5%)"
explanation: Orphanet phenotype data classifies digital clubbing as occasional (29-5%) in primary ciliary dyskinesia.
phenotype_term:
preferred_term: Clubbing
term:
id: HP:0001217
label: Clubbing
- category: Cardiac
name: Abnormal Heart Morphology
frequency: OCCASIONAL
notes: Congenital heart defects associated with laterality abnormalities
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0001627 | Abnormal heart morphology | Occasional (29-5%)"
explanation: Orphanet phenotype data classifies abnormal heart morphology as occasional (29-5%) in primary ciliary dyskinesia.
phenotype_term:
preferred_term: Abnormal heart morphology
term:
id: HP:0001627
label: Abnormal heart morphology
- category: Neurologic
name: Hydrocephalus
frequency: VERY_RARE
notes: Related to ependymal ciliary dysfunction
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0000238 | Hydrocephalus | Very rare (<4-1%)"
explanation: Orphanet phenotype data classifies hydrocephalus as very rare (<4-1%) in primary ciliary dyskinesia.
phenotype_term:
preferred_term: Hydrocephalus
term:
id: HP:0000238
label: Hydrocephalus
- category: Respiratory
name: Respiratory Failure
frequency: VERY_RARE
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0002878 | Respiratory failure | Very rare (<4-1%)"
explanation: Orphanet phenotype data classifies respiratory failure as very rare (<4-1%) in primary ciliary dyskinesia.
phenotype_term:
preferred_term: Respiratory failure
term:
id: HP:0002878
label: Respiratory failure
- category: Gastrointestinal
name: Intestinal Malrotation
frequency: VERY_RARE
notes: Associated with situs abnormalities
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "HP:0002566 | Intestinal malrotation | Very rare (<4-1%)"
explanation: Orphanet phenotype data classifies intestinal malrotation as very rare (<4-1%) in primary ciliary dyskinesia.
phenotype_term:
preferred_term: Intestinal malrotation
term:
id: HP:0002566
label: Intestinal malrotation
biochemical:
- name: Nitric Oxide
presence: Decreased
context: Lower levels in nasal and exhaled breath
evidence:
- reference: PMID:12511725
reference_title: "Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia."
supports: SUPPORT
snippet: Low values in both eNO and nNO readings (<2.4 ppb and <187 ppb, respectively) identified PCD patients from other bronchiectatic patients with a specificity of 98% and a positive predictive value of 92%.
explanation: This study shows that both exhaled nitric oxide (eNO) and nasal nitric oxide (nNO) levels are significantly lower in patients with primary ciliary dyskinesia (PCD) compared to other groups.
- reference: PMID:22408195
reference_title: "Nitric oxide in primary ciliary dyskinesia."
supports: SUPPORT
snippet: Despite chronic infections, nasal nitric oxide in such patients is markedly reduced and is used as a screening test for this condition.
explanation: This abstract confirms that nasal nitric oxide levels are significantly reduced in PCD patients.
- reference: PMID:31770003
reference_title: "Nasal Nitric Oxide Measurement in Primary Ciliary Dyskinesia. A Technical Paper on Standardized Testing Protocols."
supports: SUPPORT
snippet: Nasal nitric oxide concentrations are extremely low in primary ciliary dyskinesia (PCD), and measurement of this nasal gas is recommended as a PCD diagnostic test in cooperative patients aged 5 years and older.
explanation: This paper supports the statement by indicating that nasal nitric oxide levels are extremely low in PCD patients.
- reference: PMID:35777446
reference_title: "Longitudinal Nitric Oxide Levels and Infections by Ultrastructure and Genotype in Primary Ciliary Dyskinesia."
supports: SUPPORT
snippet: We hypothesized that differences in nasal nitric oxide (nNO) and fractional exhaled nitric oxide (Feno) relate to prognosis in primary ciliary dyskinesia (PCD).
explanation: The study indicates that both nasal nitric oxide (nNO) and fractional exhaled nitric oxide (FeNO) levels are low in PCD patients and are used to monitor the condition.
- reference: PMID:33860637
reference_title: "Breath-holding and tidal breathing nasal NO to screen children for Primary Ciliary Dyskinesia."
supports: SUPPORT
snippet: Nasal nitric oxide (nNO) measurement is recommended to screen for Primary Ciliary Dyskinesia (PCD) in subjects with suggestive history and symptoms.
explanation: This study supports the statement by recommending nasal nitric oxide measurement as a screening tool for PCD due to its low levels in such patients.
- reference: PMID:29490941
reference_title: "Olfactory dysfunction is worse in primary ciliary dyskinesia compared with other causes of chronic sinusitis in children."
supports: SUPPORT
snippet: Olfaction, nasal nitric oxide (nNO) and sinus CT were assessed in patients with PCD and non-PCD sinus disease, and healthy controls (no CT scan).
explanation: The study confirms that nasal nitric oxide levels are lower in PCD patients compared to non-PCD patients.
genetic:
- name: DNAI1
association: Pathogenic Variants
notes: Outer dynein arm intermediate chain required for ODA integrity and docking
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "DNAI1 | dynein axonemal intermediate chain 1 | hgnc:2954 | Disease-causing germline mutation(s) in"
explanation: Orphanet gene-disease association data confirms DNAI1 as a disease-causing gene for primary ciliary dyskinesia.
- reference: PMID:11893720
reference_title: "Mutations in DNAI1 (IC78) cause primary ciliary dyskinesia."
supports: SUPPORT
snippet: Mutations in DNAI1 (IC78) cause primary ciliary dyskinesia.
explanation: This study directly links mutations in DNAI1 to the cause of primary ciliary dyskinesia.
- reference: PMID:35869935
reference_title: "Pathogenic variants identified using whole-exome sequencing in Chinese patients with primary ciliary dyskinesia."
supports: SUPPORT
snippet: 13 rare variants were identified in patients with PCD, among which were three homozygous causative variants (including one splicing variant) in the PCD-associated genes CCDC40 and DNAI1.
explanation: The study identifies causative variants in DNAI1 associated with primary ciliary dyskinesia.
- reference: PMID:15750039
reference_title: "Mislocalization of DNAH5 and DNAH9 in respiratory cells from patients with primary ciliary dyskinesia."
supports: SUPPORT
snippet: The most frequent genetic defects comprise recessive mutations of DNAH5 and DNAI1, which encode outer dynein arm (ODA) components.
explanation: This study mentions DNAI1 mutations as frequent genetic defects causing primary ciliary dyskinesia.
- reference: PMID:11231901
reference_title: "Axonemal dynein intermediate-chain gene (DNAI1) mutations result in situs inversus and primary ciliary dyskinesia (Kartagener syndrome)."
supports: SUPPORT
snippet: We identified compound heterozygous DNAI1 gene defects in three independent patients and in two of their siblings who presented with PCD and situs solitus.
explanation: The study links compound heterozygous DNAI1 gene defects with primary ciliary dyskinesia.
- name: DNAH5
association: Pathogenic Variants
notes: Major axonemal outer dynein arm heavy chain generating motile force
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "DNAH5 | dynein axonemal heavy chain 5 | hgnc:2950 | Disease-causing germline mutation(s) in"
explanation: Orphanet gene-disease association data confirms DNAH5 as a disease-causing gene for primary ciliary dyskinesia.
- reference: PMID:31118369
reference_title: "A Japanese Case of Primary Ciliary Dyskinesia with DNAH5 Mutations."
supports: SUPPORT
snippet: A genetic examination detected compound heterozygous mutations of DNAH5 that encode ODA components.
explanation: The study reports a case of primary ciliary dyskinesia (PCD) with DNAH5 mutations, confirming the association between PCD and pathogenic variants in DNAH5.
- reference: PMID:36727596
reference_title: "Pathogenic variants in CLXN encoding the outer dynein arm docking-associated calcium-binding protein calaxin cause primary ciliary dyskinesia."
supports: SUPPORT
snippet: Most PCD-causing variants result in abnormal outer dynein arms (ODAs), which provide the generative force for respiratory ciliary beating and proper mucociliary clearance.
explanation: The study indicates that pathogenic variants causing PCD often result in abnormal ODAs, which are associated with DNAH5.
- name: DNAH11
association: Pathogenic Variants
notes: Outer dynein arm heavy chain often causing dyskinetic beating with near-normal ultrastructure; associated with milder lung function decline
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "DNAH11 | dynein axonemal heavy chain 11 | hgnc:2942 | Disease-causing germline mutation(s) in"
explanation: Orphanet gene-disease association data confirms DNAH11 as a disease-causing gene for primary ciliary dyskinesia.
- name: CCDC39
association: Pathogenic Variants
notes: Nexin-dynein regulatory complex scaffold for inner dynein arms; associated with severe early lung disease and low lung function
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "CCDC39 | coiled-coil domain 39 molecular ruler complex subunit | hgnc:25244 | Disease-causing germline mutation(s) in"
explanation: Orphanet gene-disease association data confirms CCDC39 as a disease-causing gene for primary ciliary dyskinesia.
- name: CCDC40
association: Pathogenic Variants
notes: Nexin-dynein regulatory complex scaffold partnering with CCDC39; associated with severe lung function decline and possible congenital heart disease
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "CCDC40 | coiled-coil domain 40 molecular ruler complex subunit | hgnc:26090 | Disease-causing germline mutation(s) in"
explanation: Orphanet gene-disease association data confirms CCDC40 as a disease-causing gene for primary ciliary dyskinesia.
- name: RSPH1
association: Pathogenic Variants
notes: Radial spoke head component coordinating central pair-dynein regulation
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "RSPH1 | radial spoke head component 1 | hgnc:12371 | Disease-causing germline mutation(s) (loss of function) in"
explanation: Orphanet gene-disease association data confirms RSPH1 as a disease-causing gene for primary ciliary dyskinesia.
- name: RSPH4A
association: Pathogenic Variants
notes: Radial spoke protein required for radial spoke integrity and coordinated beating
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "RSPH4A | radial spoke head component 4A | hgnc:21558 | Disease-causing germline mutation(s) in"
explanation: Orphanet gene-disease association data confirms RSPH4A as a disease-causing gene for primary ciliary dyskinesia.
- name: RSPH9
association: Pathogenic Variants
notes: Radial spoke head subunit impacting central pair-radial spoke interactions
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "RSPH9 | radial spoke head component 9 | hgnc:21057 | Disease-causing germline mutation(s) in"
explanation: Orphanet gene-disease association data confirms RSPH9 as a disease-causing gene for primary ciliary dyskinesia.
- name: CCNO
association: Pathogenic Variants
notes: Required for centriole amplification and multiciliogenesis; associated with oligocilia and very severe early disease with very low lung function
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "CCNO | cyclin O | hgnc:18576 | Disease-causing germline mutation(s) (loss of function) in"
explanation: Orphanet gene-disease association data confirms CCNO as a disease-causing gene for primary ciliary dyskinesia.
- name: FOXJ1
association: Pathogenic Variants
notes: Master transcription factor regulating motile ciliogenesis; can present in autosomal dominant fashion
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "FOXJ1 | forkhead box J1 | hgnc:3816 | Disease-causing germline mutation(s) (loss of function) in"
explanation: Orphanet gene-disease association data confirms FOXJ1 as a disease-causing gene for primary ciliary dyskinesia.
- name: MCIDAS
association: Pathogenic Variants
notes: Drives multiciliated cell differentiation and centriole biogenesis; associated with reduced cilia number
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "MCIDAS | multiciliate differentiation and DNA synthesis associated cell cycle protein | hgnc:40050 | Disease-causing germline mutation(s) (loss of function) in"
explanation: Orphanet gene-disease association data confirms MCIDAS as a disease-causing gene for primary ciliary dyskinesia.
- name: ODAD1
association: Pathogenic Variants
notes: Outer dynein arm docking/assembly factor; associated with relatively milder lung function impact
evidence:
- reference: ORPHA:244
supports: SUPPORT
snippet: "ODAD1 | outer dynein arm docking complex subunit 1 | hgnc:26560 | Disease-causing germline mutation(s) (loss of function) in"
explanation: Orphanet gene-disease association data confirms ODAD1 as a disease-causing gene for primary ciliary dyskinesia.
- name: CFAP221
gene_term:
preferred_term: CFAP221
term:
id: hgnc:33720
label: CFAP221
association: Pathogenic Variants
evidence:
- reference: CGGV:assertion_c7c841e5-2973-4f23-8603-970e9e2cbc92-2025-12-16T120000.000Z
reference_title: "CFAP221 / primary ciliary dyskinesia (Definitive)"
supports: SUPPORT
evidence_source: OTHER
snippet: "CFAP221 | HGNC:33720 | primary ciliary dyskinesia | MONDO:0016575 | AR | Definitive"
explanation: ClinGen classifies the CFAP221-primary ciliary dyskinesia gene-disease relationship as definitive with autosomal recessive inheritance.
- name: CFAP46
gene_term:
preferred_term: CFAP46
term:
id: hgnc:25247
label: CFAP46
association: Pathogenic Variants
evidence:
- reference: CGGV:assertion_eabe809a-1203-4d42-9052-21f39717754f-2025-10-17T160000.000Z
reference_title: "CFAP46 / primary ciliary dyskinesia (Limited)"
supports: SUPPORT
evidence_source: OTHER
snippet: "CFAP46 | HGNC:25247 | primary ciliary dyskinesia | MONDO:0016575 | AR | Limited"
explanation: ClinGen classifies the CFAP46-primary ciliary dyskinesia gene-disease relationship as limited with autosomal recessive inheritance.
- name: CFAP57
gene_term:
preferred_term: CFAP57
term:
id: hgnc:26485
label: CFAP57
association: Pathogenic Variants
evidence:
- reference: CGGV:assertion_50ed292f-0044-4c82-9419-a040cbcaf205-2022-06-23T160000.000Z
reference_title: "CFAP57 / primary ciliary dyskinesia (Limited)"
supports: SUPPORT
evidence_source: OTHER
snippet: "CFAP57 | HGNC:26485 | primary ciliary dyskinesia | MONDO:0016575 | AR | Limited"
explanation: ClinGen classifies the CFAP57-primary ciliary dyskinesia gene-disease relationship as limited with autosomal recessive inheritance.
- name: DAW1
gene_term:
preferred_term: DAW1
term:
id: hgnc:26383
label: DAW1
association: Pathogenic Variants
evidence:
- reference: CGGV:assertion_8610990f-63cf-466a-8cd7-fbf7ae58d0f2-2024-06-13T160000.000Z
reference_title: "DAW1 / primary ciliary dyskinesia (Limited)"
supports: SUPPORT
evidence_source: OTHER
snippet: "DAW1 | HGNC:26383 | primary ciliary dyskinesia | MONDO:0016575 | AR | Limited"
explanation: ClinGen classifies the DAW1-primary ciliary dyskinesia gene-disease relationship as limited with autosomal recessive inheritance.
- name: DNAH1
gene_term:
preferred_term: DNAH1
term:
id: hgnc:2940
label: DNAH1
association: Pathogenic Variants
evidence:
- reference: CGGV:assertion_a07c8b6e-a558-498b-975c-b12e96878a44-2025-10-16T160000.000Z
reference_title: "DNAH1 / primary ciliary dyskinesia (Limited)"
supports: SUPPORT
evidence_source: OTHER
snippet: "DNAH1 | HGNC:2940 | primary ciliary dyskinesia | MONDO:0016575 | AR | Limited"
explanation: ClinGen classifies the DNAH1-primary ciliary dyskinesia gene-disease relationship as limited with autosomal recessive inheritance.
- name: DNAH10
gene_term:
preferred_term: DNAH10
term:
id: hgnc:2941
label: DNAH10
association: Pathogenic Variants
evidence:
- reference: CGGV:assertion_698c6b23-a6fb-4b56-a38e-b29d5f8bbd86-2025-02-13T170000.000Z
reference_title: "DNAH10 / primary ciliary dyskinesia (Limited)"
supports: SUPPORT
evidence_source: OTHER
snippet: "DNAH10 | HGNC:2941 | primary ciliary dyskinesia | MONDO:0016575 | AR | Limited"
explanation: ClinGen classifies the DNAH10-primary ciliary dyskinesia gene-disease relationship as limited with autosomal recessive inheritance.
- name: DNAH7
gene_term:
preferred_term: DNAH7
term:
id: hgnc:18661
label: DNAH7
association: Pathogenic Variants
evidence:
- reference: CGGV:assertion_90a097d6-5127-4466-8c81-00e99dab2696-2025-02-13T170000.000Z
reference_title: "DNAH7 / primary ciliary dyskinesia (Limited)"
supports: SUPPORT
evidence_source: OTHER
snippet: "DNAH7 | HGNC:18661 | primary ciliary dyskinesia | MONDO:0016575 | AR | Limited"
explanation: ClinGen classifies the DNAH7-primary ciliary dyskinesia gene-disease relationship as limited with autosomal recessive inheritance.
- name: NME8
gene_term:
preferred_term: NME8
term:
id: hgnc:16473
label: NME8
association: Pathogenic Variants
evidence:
- reference: CGGV:assertion_57ca8383-55b6-4edd-9be2-67b1c5142ed1-2023-06-08T160000.000Z
reference_title: "NME8 / primary ciliary dyskinesia (Limited)"
supports: SUPPORT
evidence_source: OTHER
snippet: "NME8 | HGNC:16473 | primary ciliary dyskinesia | MONDO:0016575 | AR | Limited"
explanation: ClinGen classifies the NME8-primary ciliary dyskinesia gene-disease relationship as limited with autosomal recessive inheritance.
- name: SPEF2
gene_term:
preferred_term: SPEF2
term:
id: hgnc:26293
label: SPEF2
association: Pathogenic Variants
evidence:
- reference: CGGV:assertion_e137eed5-fcd8-4497-a6dc-6651062d1cf3-2025-01-09T170000.000Z
reference_title: "SPEF2 / primary ciliary dyskinesia (Definitive)"
supports: SUPPORT
evidence_source: OTHER
snippet: "SPEF2 | HGNC:26293 | primary ciliary dyskinesia | MONDO:0016575 | AR | Definitive"
explanation: ClinGen classifies the SPEF2-primary ciliary dyskinesia gene-disease relationship as definitive with autosomal recessive inheritance.
diagnosis:
- name: High-Speed Video Microscopy
notes: Assess ciliary motion and structure
evidence:
- reference: PMID:38607006
reference_title: "Advancing Primary Ciliary Dyskinesia Diagnosis through High-Speed Video Microscopy Analysis."
supports: SUPPORT
snippet: Our study implemented HSVA for the first time on the island as a tool to better diagnose and characterize the RSPH4A ... founder mutation in Puerto Rican patients.
explanation: The study demonstrates the use of High-Speed Video Microscopy Analysis (HSVA) to assess ciliary motion and pattern in patients with Primary Ciliary Dyskinesia (PCD).
- reference: PMID:29493257
reference_title: "Seeing cilia: imaging modalities for ciliary motion and clinical connections."
supports: SUPPORT
snippet: Application of imaging modalities including transmission electron microscopy, high-speed video microscopy, and micron-optical coherence tomography could improve diagnostics and be applied for precision medicine.
explanation: The review discusses the application of high-speed video microscopy among other imaging modalities to improve diagnostics in ciliopathic diseases, including PCD.
- reference: PMID:26362507
reference_title: "Diagnostic Methods in Primary Ciliary Dyskinesia."
supports: SUPPORT
snippet: We particularly focus on use of high-speed video analysis, transmission electron microscopy, nasal nitric oxide and genetic testing.
explanation: The review highlights high-speed video analysis as one of the diagnostic methods for Primary Ciliary Dyskinesia.
- name: Transmission Electron Microscopy
notes: Examines ciliary ultrastructure for diagnostic defects
evidence:
- reference: PMID:28915070
reference_title: "Value of transmission electron microscopy for primary ciliary dyskinesia diagnosis in the era of molecular medicine: Genetic defects with normal and non-diagnostic ciliary ultrastructure."
supports: PARTIAL
snippet: Transmission electron microscopy (TEM) of respiratory cilia was previously considered the gold standard diagnostic test for PCD, but 30% of all PCD cases have either normal ciliary ultrastructure or subtle changes which are non-diagnostic.
explanation: While TEM examines ciliary ultrastructure and can detect certain defects, it is not definitive for all cases of PCD, as some genetic mutations result in normal or non-diagnostic ultrastructure.
- reference: PMID:10894096
reference_title: "Ciliary assessment in bronchiectasis."
supports: SUPPORT
snippet: This brief article discusses application of the saccharine test, light microscopy assessment of ciliary beat, and transmission electron microscopy assessment of the ultrastructure of cilia.
explanation: The reference supports that TEM is used to assess ciliary ultrastructure for diagnostic purposes.
- reference: PMID:28891733
reference_title: "Application of laboratory and digital techniques for visual enhancement during the ultrastructural assessment of cilia."
supports: SUPPORT
snippet: Routine diagnostic electron microscopy of primary ciliary dyskinesia (PCD) is based on the findings of ultrastructural defects of axonemal components.
explanation: This reference confirms that TEM is used to examine ciliary ultrastructure for diagnostic defects in PCD.
- name: Nasal Nitric Oxide Test
notes: Measures nasal nitric oxide levels, typically decreased in PCD patients
evidence:
- reference: PMID:31770003
reference_title: "Nasal Nitric Oxide Measurement in Primary Ciliary Dyskinesia. A Technical Paper on Standardized Testing Protocols."
supports: SUPPORT
snippet: Nasal nitric oxide concentrations are extremely low in primary ciliary dyskinesia (PCD), and measurement of this nasal gas is recommended as a PCD diagnostic test in cooperative patients aged 5 years and older.
explanation: The abstract clearly states that nasal nitric oxide concentrations are extremely low in PCD and that measuring this gas is recommended as a diagnostic test.
- reference: PMID:29490941
reference_title: "Olfactory dysfunction is worse in primary ciliary dyskinesia compared with other causes of chronic sinusitis in children."
supports: SUPPORT
snippet: Only in classical PCD did olfaction inversely correlate with sinusitis and nNO.
explanation: The study mentions that nasal nitric oxide (nNO) levels are involved in the diagnosis of PCD.
- reference: PMID:36285978
reference_title: "Nasal Nitric Oxide Levels: Improving the Diagnosis of Primary Ciliary Dyskinesia in Puerto Rico."
supports: SUPPORT
snippet: The nNO level differentiated homozygous subjects with PCD due to the RSPH4A (c.921+3_921+6del (intronic)) founder mutation compared to healthy gender-age matched controls and subjects with VUS or negative genetic testing for PCD.
explanation: The study demonstrates that nNO levels can differentiate PCD patients from healthy controls and those with other conditions.
- reference: PMID:37385806
reference_title: "[Diagnostic value of nasal nitric oxide for children with primary ciliary dyskinesia]."
supports: SUPPORT
snippet: nNO values were significantly lower in children with PCD than in PCD symptom-similar group and nNO normal controls.
explanation: The study supports that nasal nitric oxide levels are significantly lower in children with PCD, making it a useful diagnostic tool.
- reference: PMID:22408195
reference_title: "Nitric oxide in primary ciliary dyskinesia."
supports: SUPPORT
snippet: Despite chronic infections, nasal nitric oxide in such patients is markedly reduced and is used as a screening test for this condition.
explanation: The abstract confirms that nasal nitric oxide levels are markedly reduced in PCD patients and are used as a screening test.
environmental:
- name: Air Pollution
effect: Exacerbates Symptoms
evidence:
- reference: PMID:34574829
reference_title: "Effects of Air Pollutants on Airway Diseases."
supports: SUPPORT
snippet: Air pollution decreases quality of life and life expectancy. It exacerbates acute and chronic respiratory symptoms in patients with chronic airway diseases, and increases the morbidity and risk of hospitalization associated with respiratory diseases.
explanation: The literature indicates that air pollution exacerbates respiratory symptoms in patients with chronic airway diseases, which can be inferred to include conditions like Primary Ciliary Dyskinesia (PCD).
- reference: PMID:37147124
reference_title: "Short-term air pollution exposure and exacerbation events in mild to moderate COPD: a case-crossover study within the CanCOLD cohort."
supports: SUPPORT
snippet: 'CONCLUSIONS: Short-term ambient NO2 and PM2.5 exposure were associated with increased odds of exacerbations in Canadians with mild to moderate COPD, further heightening the awareness of non-infectious triggers of COPD exacerbations'
explanation: While this study focuses on COPD, it highlights the role of air pollution in exacerbating respiratory conditions, which can be extended to other chronic respiratory diseases like PCD.
exposure_term:
preferred_term: Air pollution exposure
term:
id: ECTO:8000036
label: exposure to air pollution
treatments:
- name: Airway Clearance Techniques
description: Methods to help clear mucus from the lungs, such as chest physical therapy.
evidence:
- reference: PMID:28408202
reference_title: "Airway Clearance Techniques for Primary Ciliary Dyskinesia; is the Cystic Fibrosis literature portable?"
supports: SUPPORT
snippet: Airway clearance techniques (ACTs) are commonly recommended for patients with PCD to facilitate mucus clearance, despite a lack of evidence in this group.
explanation: The reference acknowledges the use of airway clearance techniques in patients with Primary Ciliary Dyskinesia (PCD) to help clear mucus from the lungs.
- reference: PMID:38861625
reference_title: "Postural Drainage and Vibration."
supports: SUPPORT
snippet: Airway clearance techniques (ACTs) are critical in managing respiratory conditions characterized by mucus hypersecretion and impaired clearance, such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and various neuromuscular disorders.
explanation: The reference discusses the importance of ACTs in managing conditions with mucus hypersecretion and impaired clearance, which aligns with the use of these techniques in PCD.
- reference: PMID:11376511
reference_title: "Pathophysiology and treatment of airway mucociliary clearance. A moving tale."
supports: SUPPORT
snippet: There are three principal disorders of MCC. Firstly, primary ciliary dyskinesia (PCD)...
explanation: The reference mentions PCD and discusses airway hygiene and mucociliary clearance, supporting the relevance of airway clearance techniques in PCD.
treatment_term:
preferred_term: physical therapy
term:
id: MAXO:0000011
label: physical therapy
- name: Antibiotic Therapy
description: Long-term or prophylactic antibiotics to control respiratory infections.
target_phenotypes:
- preferred_term: Recurrent Respiratory Infections
term:
id: HP:0002205
label: Recurrent respiratory infections
evidence:
- reference: PMID:28552099
reference_title: "Bacteriology and treatment of infections in the upper and lower airways in patients with primary ciliary dyskinesia: adressing the paranasal sinuses."
supports: SUPPORT
snippet: Non-functional airway cilia impair the mucociliary clearance (MCC), causing mucostasis, lung infections and destruction, chronic rhinosinusitis (CRS) and hearing impairment. It is of paramount importance to postpone chronic lung infection mainly with Gram-negative bacteria (GNB) in patients with an impaired MCC. When successful, lung function can be stabilized and quality of life (QoL) improved.
explanation: The literature mentions the importance of postponing chronic lung infection in patients with impaired MCC, which is a characteristic of PCD. This aligns with the use of long-term antibiotic therapy to manage such infections.
- reference: PMID:26586601
reference_title: "Treatment recommendations in Primary Ciliary Dyskinesia."
supports: SUPPORT
snippet: 'Most of the treatments recommended in PCD have been extrapolated from cystic fibrosis (CF) and non-CF bronchiectasis literature. Mainstays of therapy are reviewed in detail, and should include at a minimum: regular airway clearance, routine microbiological surveillance, antibiotic treatment for pulmonary exacerbation, and health vaccinations.'
explanation: The reference states that antibiotic treatment for pulmonary exacerbation is a mainstay of therapy for PCD, supporting the use of long-term or prophylactic antibiotics.
- reference: PMID:19812481
reference_title: "Antimicrobial prophylaxis for primary immunodeficiencies."
supports: SUPPORT
snippet: Antibiotic prophylaxis is one of the mainstays of therapy of primary immunodeficiencies.
explanation: While the focus is on primary immunodeficiencies, the principle of using antibiotic prophylaxis can be extended to PCD due to similar needs for managing chronic infections.
treatment_term:
preferred_term: antibiotic therapy
term:
id: NCIT:C15620
label: Antibiotic Therapy
- name: Bronchodilators
description: Medications to help open airways and ease breathing.
evidence:
- reference: PMID:36639347
reference_title: "Primary Ciliary Dyskinesia and Bronchiectasis: New Data and Future Challenges."
supports: NO_EVIDENCE
snippet: ''
explanation: The reference discusses new data and future challenges related to Primary Ciliary Dyskinesia (PCD) and bronchiectasis but does not provide specific information about the use of bronchodilators for PCD.
- reference: PMID:39269762
reference_title: "Airway Clearance Techniques in Primary Ciliary Dyskinesia: A Systematic Review."
supports: NO_EVIDENCE
snippet: Primary ciliary dyskinesia (PCD) is a respiratory disorder that impairs mucociliary clearance, leading to decreased lung function.
explanation: The reference focuses on airway clearance techniques in PCD and does not mention the use of bronchodilators.
- reference: PMID:33507585
supports: NO_EVIDENCE
snippet: ''
explanation: The reference discusses intrapulmonary percussive ventilation for PCD but does not mention bronchodilators.
- reference: PMID:37449771
supports: NO_EVIDENCE
snippet: ''
explanation: The reference discusses treatment response to pulmonary exacerbation in PCD but does not mention bronchodilators.
treatment_term:
preferred_term: bronchodilator therapy
term:
id: MAXO:0000316
label: bronchodilator therapy
- name: Nasal Steroids
description: Used to treat nasal polyps and chronic sinusitis.
evidence:
- reference: PMID:19879441
reference_title: "Corticosteroid treatment in chronic rhinosinusitis: the possibilities and the limits."
supports: PARTIAL
snippet: Long-term treatment with corticosteroid nasal spray reduces inflammation and nasal polyp size, and improves nasal symptoms such as nasal blockage, rhinorrea, and the loss of smell.
explanation: While nasal steroids are used to treat nasal polyps and chronic rhinosinusitis, the statement should specify that they are used to manage symptoms rather than being a description of Primary Ciliary Dyskinesia (PCD).
- reference: PMID:33305974
reference_title: "Exhalation Delivery Systems for Application of Intranasal Corticosteroids."
supports: PARTIAL
snippet: Topical nasal steroids play an important role in the treatment of CRS.
explanation: Nasal steroids are used in the treatment of chronic rhinosinusitis (CRS), which can be a condition associated with PCD. However, the statement should clarify that nasal steroids are for symptom management rather than a direct description of PCD.
- reference: PMID:35312075
reference_title: "Chronic Rhinosinusitis: T2r38 Genotyping and Nasal Cytology in Primary Ciliary Dyskinesia."
supports: PARTIAL
snippet: Our findings indicate for the first time that PCD patients with CRSwNP display a more severe disease than those with CRSsNP.
explanation: This reference indicates that chronic rhinosinusitis with nasal polyps (CRSwNP) is more severe in PCD patients. However, it does not directly state that nasal steroids are used to treat these conditions in the context of PCD.
- reference: PMID:28552099
reference_title: "Bacteriology and treatment of infections in the upper and lower airways in patients with primary ciliary dyskinesia: adressing the paranasal sinuses."
supports: PARTIAL
snippet: Implementing ESS with adjuvant therapy to PCD patients (I, IV) significantly ameliorated CRS symptoms.
explanation: This reference suggests that surgical and adjuvant therapies, including possibly nasal steroids, can ameliorate CRS symptoms in PCD patients. However, it does not explicitly state the use of nasal steroids.
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
- name: Hearing Aids
description: Assistive devices for hearing loss management.
evidence:
- reference: PMID:29287859
reference_title: "Hearing loss in children with primary ciliary dyskinesia."
supports: NO_EVIDENCE
snippet: 'CONCLUSIONS: Slight to mild CHL and all types of otitis media are prevalent among patients with PCD, and some of these children have sensorineural hearing loss (SNHL).'
explanation: The study discusses the prevalence and types of hearing loss in children with PCD but does not mention the use of hearing aids or other assistive devices for management.
- reference: PMID:22960754
reference_title: "Assistive hearing technologies among students with hearing impairment: factors that promote satisfaction."
supports: NO_EVIDENCE
snippet: This article explores factors pertaining to children's use of and attitudes toward hearing technologies, such as hearing aids, cochlear implants, teacher-worn microphones, and student-worn microphones.
explanation: This study focuses on the use of hearing technologies among students with hearing impairment but does not specifically address children with PCD.
- reference: PMID:28187057
reference_title: "Improvements in Gait With Hearing Aids and Cochlear Implants."
supports: NO_EVIDENCE
snippet: 'OBJECTIVE: To evaluate whether wearing auditory assistive devices can improve gait and dynamic balance.'
explanation: The study evaluates the impact of hearing assistive devices on gait and balance in adults but does not mention their use in patients with PCD.
- reference: PMID:30827358
reference_title: "Medical and Audiological Indications for Implantable Auditory Devices."
supports: NO_EVIDENCE
snippet: Implantable auditory devices (IADs) are a viable hearing restoration option for patients with hearing loss.
explanation: The article discusses implantable auditory devices as a hearing restoration option but does not specifically mention hearing aids for patients with PCD.
- reference: PMID:2062156
reference_title: "Primary ciliary dyskinesia and the middle ear."
supports: NO_EVIDENCE
snippet: In patients with primary ciliary dyskinesia, a discrepancy was found between subjective ear complaints and the actual middle ear function.
explanation: This study discusses middle ear function in patients with PCD but does not mention the use of hearing aids or other assistive devices.
treatment_term:
preferred_term: supportive care
term:
id: MAXO:0000950
label: supportive care
- name: Genetic Counseling
description: Provides information and support for affected individuals and families.
evidence:
- reference: PMID:29800551
reference_title: "Advances in the Genetics of Primary Ciliary Dyskinesia: Clinical Implications."
supports: NO_EVIDENCE
snippet: Our knowledge of cilia genetics and the function of the proteins encoded has led to a greater understanding of the clinical manifestations of motile ciliopathies. These advances have changed our approach toward diagnostic testing for primary ciliary dyskinesia.
explanation: The reference discusses advances in genetics and diagnostic testing for primary ciliary dyskinesia but does not mention genetic counseling providing information and support for affected individuals and families.
- reference: PMID:29905515
reference_title: "Diagnosis of Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice Guideline."
supports: NO_EVIDENCE
snippet: This document presents the American Thoracic Society clinical practice guidelines for the diagnosis of primary ciliary dyskinesia (PCD).
explanation: The guideline focuses on diagnostic practices and does not mention genetic counseling or support for affected individuals and families.
- reference: PMID:19410203
reference_title: "Primary ciliary dyskinesia: prospects for new therapies, building on the experience in cystic fibrosis."
supports: NO_EVIDENCE
snippet: Newer genetic modifiers show an exciting potential for personalized medication, combining selection of patients with a common genetic mutation and a drug treatment that has been specifically designed to overcome that mutation, and will greatly enhance the therapeutic arsenal for PCD.
explanation: The reference discusses potential future therapies for PCD but does not mention genetic counseling or support services.
- reference: PMID:35854386
reference_title: "Clinical and genetic spectrum of primary ciliary dyskinesia in Chinese patients: a systematic review."
supports: NO_EVIDENCE
snippet: Diagnostic delay and under-recognition of PCD remain a big issue in China, which contributes to progressive lung disease and PA infection indicating worse outcome.
explanation: The reference discusses diagnostic delays and clinical outcomes but does not mention genetic counseling or support services.
treatment_term:
preferred_term: genetic counseling
term:
id: MAXO:0000079
label: genetic counseling
experimental_models:
- name: Patient-derived nasal epithelial air-liquid interface model
description: >-
Expanded basal epithelial cells from nasal brush biopsies re-differentiated
in miniaturized air-liquid interface cultures to preserve genotype-linked
ciliary ultrastructural and motility defects in primary ciliary dyskinesia.
experimental_model_type: PRIMARY_CELL_CULTURE
namo_type: namo:TwoDCellCulture
organism:
preferred_term: human
term:
id: NCBITaxon:9606
label: Homo sapiens
tissue_term:
preferred_term: nasal cavity epithelium
term:
id: UBERON:0005384
label: nasal cavity epithelium
cell_types:
- preferred_term: respiratory ciliated cell
term:
id: CL:0002368
label: respiratory tract epithelial cell
conditions:
- primary ciliary dyskinesia
- MCIDAS-associated reduced generation of motile cilia
cell_source: Patient-derived nasal basal epithelial cells expanded from nasal brush biopsies
culture_system: Miniaturized 96-well Transwell air-liquid interface culture
publication: PMID:33795320
findings:
- statement: Patient-derived nasal ALI cultures retain genotype-linked ciliary ultrastructural and motility defects and can be used to test rescue strategies for reduced multiciliogenesis
evidence:
- reference: PMID:33795320
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Initial analyses of ciliary ultrastructure, beat pattern and beat frequency in the 96-well transwell format ALI cultures indicate that a range of different PCD defects can be retained in these cultures."
explanation: Supports use of expanded nasal ALI cultures as a disease-relevant PCD model that preserves mutation-associated ciliary defects.
- reference: PMID:33795320
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "As proof-of-principle, we performed a personalised investigation in a patient with a rare and severe form of PCD (reduced generation of motile cilia), in this case caused by a homozygous nonsense mutation in the MCIDAS gene."
explanation: Links the ALI model to a mechanistically relevant multiciliogenesis defect within a defined PCD genotype.
evidence:
- reference: PMID:33795320
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Primary cell culture of basal epithelial cells from nasal brush biopsies followed by ciliated differentiation at the air-liquid interface (ALI) has proven to be a useful tool in PCD diagnostics but the technique's broader utility, including in pre-clinical PCD research, has been restricted by the limited number of basal cells that can be expanded from such biopsies."
explanation: Establishes patient-derived nasal ALI culture as an existing PCD modeling system and motivates the expanded higher-throughput format.
- name: Patient-derived airway organoid model
description: >-
Airway organoids established from nasal inferior turbinate brush samples and
differentiated toward ciliated cells to capture patient-specific ciliary
beating abnormalities in primary ciliary dyskinesia.
experimental_model_type: ORGANOID
namo_type: namo:Organoid
organism:
preferred_term: human
term:
id: NCBITaxon:9606
label: Homo sapiens
tissue_term:
preferred_term: nasal cavity epithelium
term:
id: UBERON:0005384
label: nasal cavity epithelium
cell_types:
- preferred_term: respiratory ciliated cell
term:
id: CL:0002368
label: respiratory tract epithelial cell
conditions:
- primary ciliary dyskinesia
cell_source: Patient-derived nasal inferior turbinate epithelial cells expanded as airway organoids
culture_system: Long-term expandable airway organoid culture with ciliated differentiation
publication: PMID:34693619
findings:
- statement: Patient-derived airway organoids reproduce mutation-linked differences in ciliary beating and support genotype-specific functional interrogation
evidence:
- reference: PMID:34693619
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Patient-specific differences in ciliary beating are observed and are in agreement with the patients' genetic mutations."
explanation: Supports the organoid model as a genotype-resolved readout of the ciliary dysfunction central to PCD.
- reference: PMID:34693619
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "More detailed organoid ciliary phenotypes can thus be documented in addition to the standard diagnostic procedure."
explanation: Supports use of organoids for mechanistically richer ciliary phenotyping in PCD.
evidence:
- reference: PMID:34693619
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "We apply this condition to AOs established from nasal inferior turbinate brush samples of patients suffering from primary ciliary dyskinesia (PCD), a pulmonary disease caused by dysfunction of the motile cilia in the airways."
explanation: Establishes patient-derived airway organoids as a directly disease-relevant non-animal model for PCD.
- name: Patient-specific hiPSC-derived airway epithelium model
description: >-
Human induced pluripotent stem cell-derived airway epithelium differentiated
at air-liquid interface to model structural ciliary defects and impaired
mucociliary transport in genetically defined primary ciliary dyskinesia.
experimental_model_type: IPSC_DERIVED_MODEL
namo_type: namo:TwoDCellCulture
organism:
preferred_term: human
term:
id: NCBITaxon:9606
label: Homo sapiens
tissue_term:
preferred_term: respiratory airway
term:
id: UBERON:0001005
label: respiratory airway
cell_types:
- preferred_term: respiratory ciliated cell
term:
id: CL:0002368
label: respiratory tract epithelial cell
conditions:
- primary ciliary dyskinesia
- DNAH5-associated primary ciliary dyskinesia
- NME5-associated primary ciliary dyskinesia
cell_source: Patient-specific induced pluripotent stem cell lines differentiated into ciliated airway epithelium
culture_system: Air-liquid interface differentiation of hiPSC-derived airway epithelium
publication: PMID:37296588
findings:
- statement: Patient-specific hiPSC-derived airway epithelium reproduces molecular, ultrastructural, and functional ciliary defects, including impaired mucociliary transport
evidence:
- reference: PMID:37296588
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Applying transmission electron microscopy, immunofluorescence staining, ciliary beat frequency, and mucociliary transport measurements, we could demonstrate that ciliated respiratory epithelia cells derived from two PCD patient-specific hiPSC lines carrying mutations in DNAH5 and NME5, respectively, recapitulate the respective diseased phenotype on a molecular, structural and functional level."
explanation: Shows that hiPSC-derived airway epithelium reproduces the molecular and functional consequences of PCD mutations, including impaired transport.
evidence:
- reference: PMID:37296588
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Here, we developed an in vitro model for PCD based on human induced pluripotent stem cell (hiPSC)-derived airway epithelium in Air-Liquid-Interface cultures."
explanation: Establishes hiPSC-derived airway epithelium as a PCD-specific in vitro model.
- reference: PMID:37296588
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Motile cilia dysfunction results in diminished mucociliary clearance (MCC) of pathogens in the respiratory tract and chronic airway inflammation and infections successively causing progressive lung damage."
explanation: Connects the model's mucociliary transport readouts to the central airway pathophysiology of PCD.
disease_term:
preferred_term: primary ciliary dyskinesia
term:
id: MONDO:0016575
label: primary ciliary dyskinesia
classifications:
harrisons_chapter:
- classification_value: RESPIRATORY
- classification_value: GENETICS_ENVIRONMENT_DISEASE
mechanistic_category:
- classification_value: ciliopathy
references:
- reference: DOI:10.1007/s40291-025-00801-w
title: 'Clinical, Genetic, Morphological and Functional Correlations in a Large Series of Patients with Primary Ciliary Dyskinesia: A Heterogeneous Disease with a Controversial Diagnosis'
findings: []
- reference: DOI:10.1183/13993003.01769-2023
title: Analyses of 1236 genotyped primary ciliary dyskinesia individuals identify regional clusters of distinct DNA variants and significant genotype–phenotype correlations
findings: []
- reference: DOI:10.1542/peds.2023-063064
title: Primary Ciliary Dyskinesia
findings: []
- reference: DOI:10.29057/mjmr.v12i24.12347
title: 'Exploring In Vitro Models: Advances and Challenges in Human Respiratory Tract Research'
findings: []
- reference: DOI:10.3390/cells13110974
title: 'Primary Ciliary Dyskinesia: A Clinical Review'
findings: []
Disease Pathophysiology Research Report
Target Disease - Disease Name: Primary Ciliary Dyskinesia (PCD) - MONDO ID: not confidently resolved here; will populate upon ontology verification from MONDO database. - Category: Genetic (motile ciliopathy)
Pathophysiology description Primary ciliary dyskinesia is a motile ciliopathy caused by mutations affecting axonemal structures (outer/inner dynein arms, radial spokes, central pair apparatus, nexin–dynein regulatory complex) or the multiciliogenesis program, resulting in abnormal or absent motile cilia and impaired mucociliary clearance; nodal motile cilia dysfunction during embryogenesis underlies laterality defects (e.g., situs inversus/ambiguus) (URL: https://doi.org/10.1542/peds.2023-063064; May 2024) (wee2024primaryciliarydyskinesia. pages 1-3). “Mutations impair axonemal dynein arms, dynein regulatory/nexin complexes, or ciliogenesis factors, producing defective or absent motile cilia and impaired mucociliary clearance” (URL: https://doi.org/10.1542/peds.2023-063064; May 2024) (wee2024primaryciliarydyskinesia. pages 3-4). Clinically, impaired clearance leads to neonatal respiratory distress, chronic wet cough, persistent rhinosinusitis/otitis media, progressive bronchiectasis, and subfertility; laterality defects reflect embryonic nodal cilia malfunction (URL: https://doi.org/10.1542/peds.2023-063064; May 2024) (wee2024primaryciliarydyskinesia. pages 1-3). No single diagnostic gold standard exists; multimodal testing with nasal nitric oxide (nNO), high-speed videomicroscopy (HSVM), transmission electron microscopy (TEM), immunofluorescence (IF), and genetics is recommended (URL: https://doi.org/10.3390/cells13110974; Jun 2024) (despotes2024primaryciliarydyskinesia pages 16-17).
Key concepts and definitions - Motile cilium axoneme (cellular component): canonical 9+2 microtubule doublets with outer dynein arms (ODA), inner dynein arms (IDA), radial spokes (RS), central pair (CP), nexin–dynein regulatory complex (N-DRC); coordinated beating generates mucociliary transport (URL: https://doi.org/10.1542/peds.2023-063064; May 2024) (wee2024primaryciliarydyskinesia. pages 1-3). - Multiciliogenesis (biological process): centriole amplification and motile cilia generation driven by transcriptional regulators (FOXJ1, MCIDAS) and cell cycle–linked factors (e.g., CCNO); defects cause oligocilia/aplasia (URL: https://doi.org/10.1542/peds.2023-063064; May 2024; URL: https://doi.org/10.3390/cells13110974; Jun 2024) (wee2024primaryciliarydyskinesia. pages 1-3, despotes2024primaryciliarydyskinesia pages 16-17). - Nodal cilia: motile 9+0 cilia generating embryonic leftward flow; defects randomize L–R patterning (URL: https://doi.org/10.3390/cells13110974; Jun 2024) (despotes2024primaryciliarydyskinesia pages 1-2).
1) Core Pathophysiology - Primary mechanisms: loss or misassembly of ODA/IDA complexes, defects of RS/CP/N‑DRC, and failure of ODA docking or dynein assembly cause abnormal waveform, reduced beat frequency, or immotility; multiciliogenesis defects cause markedly reduced cilia number (URL: https://doi.org/10.1542/peds.2023-063064; May 2024; URL: https://doi.org/10.3390/cells13110974; Jun 2024) (wee2024primaryciliarydyskinesia. pages 3-4, wee2024primaryciliarydyskinesia. pages 1-3, despotes2024primaryciliarydyskinesia pages 16-17). - Downstream cellular consequences: impaired mucociliary clearance → mucus stasis, recurrent bacterial infection, epithelial injury, chronic neutrophilic inflammation, and progressive airway remodeling/bronchiectasis (URL: https://doi.org/10.1542/peds.2023-063064; May 2024) (wee2024primaryciliarydyskinesia. pages 3-4). - Developmental mechanism: nodal cilia dysfunction drives laterality defects (situs inversus/ambiguus), present in a substantial subset (URL: https://doi.org/10.1542/peds.2023-063064; May 2024) (wee2024primaryciliarydyskinesia. pages 1-3).
2) Key Molecular Players (genes/proteins; ontology-ready summary) | Gene (HGNC) | Category | Axonemal / assembly role | Key cellular component (GO-style) | Disrupted biological process (GO-style) | Representative phenotype associations | Evidence (citation, DOI/URL) | |---|---|---|---|---|---|---| | DNAH5 | ODA (outer dynein arm) | Major axonemal heavy chain generating motile force | Axonemal outer dynein arm | Cilium movement; axoneme function | Recurrent airway infections, bronchiectasis; laterality defects common | (raidt2024analysesof1236 pages 8-10) https://doi.org/10.1183/13993003.01769-2023 | | DNAI1 | ODA (intermediate chain) | Structural/intermediate chain required for ODA integrity and docking | Axonemal outer dynein arm | Outer dynein arm assembly; cilium movement | Chronic wet cough, bronchiectasis; neonatal respiratory distress; situs inversus | (a.2025primaryciliarydyskinesia pages 2-3) https://doi.org/10.17615/qgfk-y329, (raidt2024analysesof1236 pages 8-10) https://doi.org/10.1183/13993003.01769-2023 | | DNAH11 | ODA (heavy chain) | Heavy chain with functional role; often causes dyskinetic beating with near-normal TEM | Axonemal dynein arm | Ciliary beating regulation; cilium movement | Variable lung function (milder FEV1 reduction); atypical/normal TEM; respiratory symptoms | (raidt2024analysesof1236 pages 8-10) https://doi.org/10.1183/13993003.01769-2023, (wee2024primaryciliarydyskinesia. pages 3-4) https://doi.org/10.1542/peds.2023-063064 | | CCDC39 | N-DRC / assembly scaffold | Scaffolding for inner dynein arms and nexin-dynein regulatory complex assembly | Nexin-dynein regulatory complex; inner dynein arm | Axoneme assembly; dynein arm docking | Severe early lung disease; low FEV1; neonatal distress; bronchiectasis | (raidt2024analysesof1236 pages 8-10) https://doi.org/10.1183/13993003.01769-2023, (wee2024primaryciliarydyskinesia. pages 1-3) https://doi.org/10.1542/peds.2023-063064 | | CCDC40 | N-DRC / assembly scaffold | Partners with CCDC39 to position IDAs and N-DRC during axoneme assembly | Nexin-dynein regulatory complex; axoneme | Axoneme assembly; microtubule organization | Severe lung function decline (low FEV1); bronchiectasis; congenital heart disease association noted | (raidt2024analysesof1236 pages 8-10) https://doi.org/10.1183/13993003.01769-2023, (despotes2024primaryciliarydyskinesia pages 16-17) https://doi.org/10.3390/cells13110974 | | RSPH1 | Radial spoke head | Radial spoke head component coordinating CP–dynein regulation | Radial spoke (axoneme) | Regulation of axonemal dynein activity; central pair organization | Central-pair related defects; typical respiratory disease; laterality less associated | (despotes2024primaryciliarydyskinesia pages 16-17) https://doi.org/10.3390/cells13110974, (raidt2024analysesof1236 pages 8-10) https://doi.org/10.1183/13993003.01769-2023 | | RSPH4A | Radial spoke head | Radial spoke protein required for RS integrity and coordinated beating | Radial spoke (axoneme) | Regulation of ciliary beating; central pair-dependent signaling | Respiratory disease, sinusitis, possible hearing involvement reported in case series | (despotes2024primaryciliarydyskinesia pages 16-17) https://doi.org/10.3390/cells13110974, (despotes2024primaryciliarydyskinesia pages 1-2) https://doi.org/10.3390/cells13110974 | | RSPH9 | Radial spoke head | Radial spoke head subunit impacting CP–RS interactions | Radial spoke (axoneme) | Regulation of dynein-driven motility; cilium movement | Respiratory symptoms; genotype-specific laterality patterns (less frequent) | (raidt2024analysesof1236 pages 8-10) https://doi.org/10.1183/13993003.01769-2023, (despotes2024primaryciliarydyskinesia pages 16-17) https://doi.org/10.3390/cells13110974 | | CCNO | Ciliogenesis / multiciliogenesis | Required for centriole amplification and generation of multiple motile cilia | Basal bodies / centrioles; apical cytoplasm | Multiciliogenesis; cilium assembly | Oligocilia / reduced cilia number; severe early disease, very low FEV1 (worse prognosis) | (raidt2024analysesof1236 pages 8-10) https://doi.org/10.1183/13993003.01769-2023, (despotes2024primaryciliarydyskinesia pages 16-17) https://doi.org/10.3390/cells13110974 | | FOXJ1 | Ciliogenesis transcription factor | Master regulator of motile ciliogenesis (transcriptional control) | Nucleus (transcription regulator controlling cilium assembly) | Regulation of cilium assembly; multiciliogenesis | Oligocilia/absent cilia phenotypes; laterality defects; autosomal-dominant presentations described | (wee2024primaryciliarydyskinesia. pages 1-3) https://doi.org/10.1542/peds.2023-063064, (a.2025primaryciliarydyskinesia pages 2-3) https://doi.org/10.17615/qgfk-y329 | | MCIDAS | Ciliogenesis / multiciliated cell differentiation | Drives multiciliated cell differentiation and centriole biogenesis program | Nucleus; transcriptional complex controlling centriole amplification | Multiciliogenesis; centriole assembly | Reduced cilia number, neonatal distress, chronic airway disease | (despotes2024primaryciliarydyskinesia pages 16-17) https://doi.org/10.3390/cells13110974, (wee2024primaryciliarydyskinesia. pages 1-3) https://doi.org/10.1542/peds.2023-063064 | | ODAD1 | ODA docking / assembly factor | Factor involved in ODA docking/assembly to doublet microtubules | Outer dynein arm docking complex | Outer dynein arm docking; axonemal assembly | Respiratory disease with relatively milder FEV1 impact vs severe scaffold defects | (raidt2024analysesof1236 pages 8-10) https://doi.org/10.1183/13993003.01769-2023 |
Table: Compact ontology-ready table listing key PCD genes, their axonemal/assembly roles, affected cellular components and processes, representative phenotypes, and primary evidence (context citations with DOIs) to support integration into a knowledge base. Narrative notes: - ODA heavy and intermediate chain genes (DNAH5, DNAI1) and the ODA heavy chain DNAH11 are among the most frequent PCD genotypes in international cohorts (URL: https://doi.org/10.1183/13993003.01769-2023; Jun 2024) (raidt2024analysesof1236 pages 8-10). - IDA/N‑DRC scaffolds CCDC39 and CCDC40 are associated with severe phenotypes and lower lung function (URL: https://doi.org/10.1183/13993003.01769-2023; Jun 2024) (raidt2024analysesof1236 pages 8-10). - Radial spoke head proteins (RSPH1, RSPH4A, RSPH9) affect CP–RS regulation and are linked to distinctive ultrastructural or functional signatures, often without laterality defects (URL: https://doi.org/10.3390/cells13110974; Jun 2024) (despotes2024primaryciliarydyskinesia pages 16-17). - Multiciliogenesis genes (FOXJ1, MCIDAS, CCNO) yield oligocilia/immotile phenotypes; FOXJ1 can present in autosomal dominant fashion (URL: https://doi.org/10.1542/peds.2023-063064; May 2024) (wee2024primaryciliarydyskinesia. pages 1-3). - Additional docking/assembly factors (e.g., ODAD1, CCDC103, CCDC114, ZMYND10, DRC1/CCDC164, HYDIN) contribute to dynein assembly/docking or CP integrity; defects can yield typical respiratory PCD with variable diagnostic signatures (URL: https://doi.org/10.17615/qgfk-y329; 2025) (a.2025primaryciliarydyskinesia pages 2-3).
3) Biological Processes (GO-style) disrupted - Cilium movement; microtubule-based movement; mucociliary clearance (respiratory epithelium) (wee2024primaryciliarydyskinesia. pages 1-3). - Axoneme assembly; dynein arm assembly (ODA/IDA); radial spoke organization; central apparatus organization; ODA docking (despotes2024primaryciliarydyskinesia pages 16-17, a.2025primaryciliarydyskinesia pages 2-3). - Multiciliogenesis and centriole amplification; cilium morphogenesis (wee2024primaryciliarydyskinesia. pages 1-3, despotes2024primaryciliarydyskinesia pages 16-17). - Embryonic left–right pattern specification via nodal flow (despotes2024primaryciliarydyskinesia pages 1-2).
4) Cellular Components (GO-style) - Axoneme (9+2); outer dynein arm; inner dynein arm; radial spoke; central pair apparatus; nexin–dynein regulatory complex; outer dynein arm docking complex; basal bodies/centrioles (wee2024primaryciliarydyskinesia. pages 1-3, despotes2024primaryciliarydyskinesia pages 16-17, a.2025primaryciliarydyskinesia pages 2-3).
5) Disease Progression - Molecular defect (axonemal structure or ciliogenesis program) → abnormal/absent ciliary beating or oligocilia → impaired mucociliary clearance → persistent sino-oto-pulmonary infections and neutrophilic inflammation → airway remodeling with bronchiectasis and progressive lung function decline; concurrent nodal cilia dysfunction in embryogenesis leads to situs inversus/ambiguus; sperm flagellar defects contribute to subfertility (URL: https://doi.org/10.1542/peds.2023-063064; May 2024) (wee2024primaryciliarydyskinesia. pages 1-3). - Quote: “Diagnosis relies on a combination of tests… including nasal nitric oxide (nNO) measurements, high-speed videomicroscopy analysis (HSVMA), immunofluorescent staining, axonemal ultrastructure analysis via transmission electron microscopy (TEM), and genetic testing. Notably, there is no single gold standard” (Cells; Jun 2024; URL: https://doi.org/10.3390/cells13110974) (despotes2024primaryciliarydyskinesia pages 16-17).
6) Phenotypic Manifestations (HPO-style) - Chronic wet cough, recurrent lower respiratory tract infections, bronchiectasis (HP:0002206), chronic rhinosinusitis (HP:0011107), chronic otitis media with effusion and conductive hearing loss (HP:0000407), neonatal respiratory distress (HP:0002643), laterality defects—situs inversus totalis (HP:0001696), situs ambiguus (HP:0003364), subfertility/infertility (HP:0000789) (wee2024primaryciliarydyskinesia. pages 1-3, despotes2024primaryciliarydyskinesia pages 16-17).
Genotype–phenotype correlations, statistics, and expert analyses (2023–2024 priority) - Multinational ERJ 2024 cohort (n=1,236; 19 countries; 908 distinct pathogenic variants, 46 genes) reported: “The prevalence of laterality defects… varied widely among countries… The prevalence of laterality defects was significantly lower in PCD individuals without pathognomonic ciliary ultrastructure defects (18%). … Median FEV1 z-scores were significantly lower in CCNO (−3.26), CCDC39 (−2.49) and CCDC40 (−2.96)… milder in DNAH11 (−0.83) and ODAD1 (−0.85)” (URL: https://doi.org/10.1183/13993003.01769-2023; Jun 2024) (raidt2024analysesof1236 pages 8-10). - Frequent genes in international datasets include DNAH5, DNAH11, CCDC40, DNAI1, CCDC39 (URL: https://doi.org/10.1183/13993003.01769-2023; Jun 2024) (raidt2024analysesof1236 pages 8-10). - Clinical spectrum and evolving diagnostics summarized by Pediatrics 2024: “PCD is a rare, genetic disease characterized by dysfunctional motile cilia and abnormal mucociliary clearance, resulting in chronic sino-oto-pulmonary disease, neonatal respiratory distress, subfertility, and organ laterality defects” (URL: https://doi.org/10.1542/peds.2023-063064; May 2024) (wee2024primaryciliarydyskinesia. pages 1-3).
Diagnostics and real-world implementation - nNO: ATS-endorsed adjunctive test from age ≥5 years; very low nNO is highly suggestive but normal nNO does not exclude PCD; chemiluminescence methods and threshold use are discussed in Pediatrics 2024 (URL: https://doi.org/10.1542/peds.2023-063064; May 2024) (wee2024primaryciliarydyskinesia. pages 3-4, wee2024primaryciliarydyskinesia. pages 1-3). - HSVM: analysis of ciliary beat frequency and waveform from nasal brushings complements TEM and genetics (URL: https://doi.org/10.3390/cells13110974; Jun 2024) (despotes2024primaryciliarydyskinesia pages 16-17). - TEM and IF: TEM detects hallmark ultrastructural class 1/2 defects in many but not all genotypes; IF for axonemal proteins (e.g., DNAH5, DNAI2) increases diagnostic sensitivity and speed (URL: https://doi.org/10.3390/cells13110974; Jun 2024; URL: https://doi.org/10.14288/1.0445067; Jan 2025) (despotes2024primaryciliarydyskinesia pages 16-17, weir2025radiantcilia pages 115-118). Quote: an immunofluorescence panel “can increase sensitivity, reduce cost and time, and will also allow for the earlier diagnosis of PCD,” though it is “insensitive to ciliogenesis defects (CCNO, MCIDAS, and FOXJ1)” (URL: https://doi.org/10.14288/1.0445067; Jan 2025) (weir2025radiantcilia pages 115-118). - Genetics: >50 causative genes; first gene DNAI1; genetics now central to diagnosis with ~70–80% yield depending on panels and CNV detection (URL: https://doi.org/10.1542/peds.2023-063064; May 2024; URL: https://doi.org/10.3390/cells13110974; Jun 2024) (wee2024primaryciliarydyskinesia. pages 1-3, despotes2024primaryciliarydyskinesia pages 16-17). - Real-world diagnostic performance: multimodal pathways combining HSVM, TEM, nNO, and genetics are required; in large clinical series, a substantial minority may have normal TEM; genetic and functional assays help close gaps (URL: https://doi.org/10.1007/s40291-025-00801-w; Jul 2025) (carreterovilarroig2025clinicalgeneticmorphological pages 1-2).
Recent developments and latest research (2023–2024) - State-of-the-art overview (Pediatrics 2024) highlighting expanded phenotype spectrum, “novel diagnostics, genotype-phenotype correlations, long term morbidity, and innovative therapeutics” (URL: https://doi.org/10.1542/peds.2023-063064; May 2024) (wee2024primaryciliarydyskinesia. pages 1-3). - ERJ 2024 multinational registry analysis (n=1,236) providing robust genotype–phenotype correlations (laterality, lung function) and regional founder variants; a key resource for precision diagnostics/prognosis (URL: https://doi.org/10.1183/13993003.01769-2023; Jun 2024) (raidt2024analysesof1236 pages 8-10). - Clinical review (Cells 2024) consolidating structural biology, genetics (>50 genes), and multi-test diagnostics; emphasizes no gold standard and ongoing management trials (URL: https://doi.org/10.3390/cells13110974; Jun 2024) (despotes2024primaryciliarydyskinesia pages 16-17).
Current applications and models - Patient-derived airway sampling for HSVM/TEM/IF/genetics is routine in specialized centers; early diagnosis improves outcomes (URL: https://doi.org/10.3390/cells13110974; Jun 2024; URL: https://doi.org/10.14288/1.0445067; Jan 2025) (despotes2024primaryciliarydyskinesia pages 16-17, weir2025radiantcilia pages 115-118). - Emerging in vitro models: reviews emphasize air–liquid interface and organoid-based respiratory models to study ciliary dysfunction and test therapies; these platforms are increasingly applied across airway diseases (URL: https://doi.org/10.29057/mjmr.v12i24.12347; Jul 2024) (raidt2024analysesof1236 pages 8-10, despotes2024primaryciliarydyskinesia pages 16-17). Note: general airway model insights support PCD translational research but are not PCD-specific in the cited review (raidt2024analysesof1236 pages 8-10).
Expert opinions and guideline-aligned analysis - Pediatrics 2024 and Cells 2024 reviews (including authors from leading PCD centers) stress a multimodal diagnostic algorithm and the heterogeneity of clinical manifestations; both advocate timely referral and comprehensive genetics to guide prognosis and research enrollment (URLs above) (wee2024primaryciliarydyskinesia. pages 1-3, despotes2024primaryciliarydyskinesia pages 16-17). - Quote: “There is no gold standard to diagnose PCD” (Cells 2024) underscoring the need for integrated testing and expert interpretation (URL: https://doi.org/10.3390/cells13110974; Jun 2024) (despotes2024primaryciliarydyskinesia pages 16-17).
Relevant statistics and data (recent) - 1,236 genotyped individuals; 908 variants in 46 genes; laterality overall 42%, but 18% in those without pathognomonic TEM defects (ERJ; Jun 2024) (raidt2024analysesof1236 pages 8-10). - Lung function by genotype: CCNO, CCDC39, CCDC40 show lowest median FEV1 z-scores (−3.26, −2.49, −2.96 respectively), DNAH11 and ODAD1 comparatively milder reductions (−0.83, −0.85) (ERJ; Jun 2024) (raidt2024analysesof1236 pages 8-10).
Ontology-style annotations for knowledge base integration - Gene/protein annotations: see embedded table for HGNC symbols and roles (raidt2024analysesof1236 pages 8-10, wee2024primaryciliarydyskinesia. pages 1-3, despotes2024primaryciliarydyskinesia pages 16-17, a.2025primaryciliarydyskinesia pages 2-3). - Biological processes (GO-style): cilium movement; axoneme assembly; dynein arm assembly and docking; radial spoke organization; multiciliogenesis; embryonic left–right patterning (wee2024primaryciliarydyskinesia. pages 1-3, despotes2024primaryciliarydyskinesia pages 16-17, despotes2024primaryciliarydyskinesia pages 1-2). - Cellular components (GO-style): axoneme; outer/inner dynein arm; radial spoke; central pair apparatus; nexin–dynein regulatory complex; outer dynein arm docking complex; basal body/centriole (wee2024primaryciliarydyskinesia. pages 1-3, despotes2024primaryciliarydyskinesia pages 16-17, a.2025primaryciliarydyskinesia pages 2-3). - Cell types (CL-style): multiciliated epithelial cell of the respiratory tract; ependymal multiciliated cell; fallopian tube epithelium; spermatid/sperm flagellated cell (wee2024primaryciliarydyskinesia. pages 1-3, despotes2024primaryciliarydyskinesia pages 16-17). - Anatomical locations (UBERON-style): nasal cavity, paranasal sinus, eustachian tube/middle ear, trachea/bronchi, lung, embryonic node, fallopian tube, ventricular ependyma (wee2024primaryciliarydyskinesia. pages 1-3, despotes2024primaryciliarydyskinesia pages 16-17). - Phenotypes (HPO-style): neonatal respiratory distress; chronic wet cough; chronic rhinosinusitis; otitis media with hearing loss; bronchiectasis; situs inversus/ambiguus; male infertility (wee2024primaryciliarydyskinesia. pages 1-3, despotes2024primaryciliarydyskinesia pages 16-17). - Chemical entities (CHEBI-style, examples used in management/research): nitric oxide (nNO biomarker); macrolide (azithromycin) for exacerbation reduction in RCTs cited by reviews; antibiotic/airway clearance adjuncts (despotes2024primaryciliarydyskinesia pages 16-17, wee2024primaryciliarydyskinesia. pages 1-3).
Emerging therapies and future directions - Reviews emphasize lack of approved cilia-restorative therapies; management focuses on airway clearance, infection control, and, in some settings, macrolides to reduce exacerbations; ongoing advances in genetics and cell models aim to enable genotype-directed therapies (URL: https://doi.org/10.3390/cells13110974; Jun 2024; URL: https://doi.org/10.1542/peds.2023-063064; May 2024) (despotes2024primaryciliarydyskinesia pages 16-17, wee2024primaryciliarydyskinesia. pages 1-3).
Evidence Items (with URLs and dates) - Wee WB et al. Primary Ciliary Dyskinesia. Pediatrics. May 2024. URL: https://doi.org/10.1542/peds.2023-063064 (wee2024primaryciliarydyskinesia. pages 1-3, wee2024primaryciliarydyskinesia. pages 3-4) (wee2024primaryciliarydyskinesia. pages 1-3, wee2024primaryciliarydyskinesia. pages 3-4). - Raidt J et al. ERJ. Analyses of 1,236 genotyped PCD individuals… Jun 2024. URL: https://doi.org/10.1183/13993003.01769-2023 (raidt2024analysesof1236 pages 8-10). - Despotes KA et al. Cells. Primary ciliary dyskinesia: a clinical review. Jun 2024. URL: https://doi.org/10.3390/cells13110974 (despotes2024primaryciliarydyskinesia pages 16-17, despotes2024primaryciliarydyskinesia pages 1-2). - Zariwala MA et al. Primary Ciliary Dyskinesia (UNC Text). 2025. URL: https://doi.org/10.17615/qgfk-y329 (a.2025primaryciliarydyskinesia pages 2-3). - Weir M. Radiant cilia: advancing North American PCD diagnosis with immunofluorescence. Jan 2025. URL: https://doi.org/10.14288/1.0445067 (weir2025radiantcilia pages 115-118). - Carretero-Vilarroig L et al. Molecular Diagnosis & Therapy. Jul 2025. URL: https://doi.org/10.1007/s40291-025-00801-w (carreterovilarroig2025clinicalgeneticmorphological pages 1-2).
Direct supporting quotes - “PCD is a rare, genetic disease characterized by dysfunctional motile cilia and abnormal mucociliary clearance, resulting in chronic sino-oto-pulmonary disease, neonatal respiratory distress, subfertility, and organ laterality defects” (Pediatrics 2024; URL above) (wee2024primaryciliarydyskinesia. pages 1-3). - “There is no gold standard to diagnose PCD” (Cells 2024; URL above) (despotes2024primaryciliarydyskinesia pages 16-17). - “The prevalence of laterality defects was significantly lower in PCD individuals without pathognomonic ciliary ultrastructure defects (18%). … Median FEV1 z-scores were significantly lower in CCNO (−3.26), CCDC39 (−2.49) and CCDC40 (−2.96)… milder in DNAH11 (−0.83) and ODAD1 (−0.85)” (ERJ 2024; URL above) (raidt2024analysesof1236 pages 8-10).
Limitations and gaps - While airway organoid/ALI and genetic therapy concepts are promising, PCD-specific interventional data remain limited in the cited 2023–2024 sources; ongoing registries and translational platforms are expected to enable genotype-targeted trials (wee2024primaryciliarydyskinesia. pages 1-3, despotes2024primaryciliarydyskinesia pages 16-17).
References
(wee2024primaryciliarydyskinesia. pages 1-3): Wallace B. Wee, BreAnna Kinghorn, Stephanie D. Davis, Thomas W. Ferkol, and Adam J. Shapiro. Primary ciliary dyskinesia. Pediatrics, May 2024. URL: https://doi.org/10.1542/peds.2023-063064, doi:10.1542/peds.2023-063064. This article has 27 citations and is from a highest quality peer-reviewed journal.
(raidt2024analysesof1236 pages 8-10): Johanna Raidt, Sarah Riepenhausen, Petra Pennekamp, Heike Olbrich, Israel Amirav, Rodrigo A. Athanazio, Micha Aviram, Juan E. Balinotti, Ophir Bar-On, Sebastian F.N. Bode, Mieke Boon, Melissa Borrelli, Siobhan B. Carr, Suzanne Crowley, Eleonora Dehlink, Sandra Diepenhorst, Peter Durdik, Bernd Dworniczak, Nagehan Emiralioğlu, Ela Erdem, Rossella Fonnesu, Serena Gracci, Jörg Große-Onnebrink, Karolina Gwozdziewicz, Eric G. Haarman, Christine R. Hansen, Claire Hogg, Mathias G. Holgersen, Eitan Kerem, Robert W. Körner, Karsten Kötz, Panayiotis Kouis, Michael R. Loebinger, Natalie Lorent, Jane S. Lucas, Debora Maj, Marcus A. Mall, June K. Marthin, Vendula Martinu, Henryk Mazurek, Hannah M. Mitchison, Tabea Nöthe-Menchen, Ugur Özçelik, Massimo Pifferi, Andrzej Pogorzelski, Felix C. Ringshausen, Jobst F. Roehmel, Sandra Rovira-Amigo, Nisreen Rumman, Anne Schlegtendal, Amelia Shoemark, Synne Sperstad Kennelly, Ben O. Staar, Sivagurunathan Sutharsan, Simon Thomas, Nicola Ullmann, Julian Varghese, Sandra von Hardenberg, Woolf T. Walker, Martin Wetzke, Michal Witt, Panayiotis Yiallouros, Anna Zschocke, Ewa Ziętkiewicz, Kim G. Nielsen, and Heymut Omran. Analyses of 1236 genotyped primary ciliary dyskinesia individuals identify regional clusters of distinct dna variants and significant genotype–phenotype correlations. European Respiratory Journal, 64:2301769, Jun 2024. URL: https://doi.org/10.1183/13993003.01769-2023, doi:10.1183/13993003.01769-2023. This article has 51 citations and is from a highest quality peer-reviewed journal.
(wee2024primaryciliarydyskinesia. pages 3-4): Wallace B. Wee, BreAnna Kinghorn, Stephanie D. Davis, Thomas W. Ferkol, and Adam J. Shapiro. Primary ciliary dyskinesia. Pediatrics, May 2024. URL: https://doi.org/10.1542/peds.2023-063064, doi:10.1542/peds.2023-063064. This article has 27 citations and is from a highest quality peer-reviewed journal.
(despotes2024primaryciliarydyskinesia pages 16-17): Katherine A. Despotes, Maimoona A. Zariwala, Stephanie D. Davis, and Thomas W. Ferkol. Primary ciliary dyskinesia: a clinical review. Cells, 13:974, Jun 2024. URL: https://doi.org/10.3390/cells13110974, doi:10.3390/cells13110974. This article has 64 citations and is from a poor quality or predatory journal.
(a.2025primaryciliarydyskinesia pages 2-3): Maimoona A. Zariwala, Peadar G. Noone, and Jason Lobo. Primary ciliary dyskinesia. Text, 2025. URL: https://doi.org/10.17615/qgfk-y329, doi:10.17615/qgfk-y329. This article has 243 citations and is from a peer-reviewed journal.
(despotes2024primaryciliarydyskinesia pages 1-2): Katherine A. Despotes, Maimoona A. Zariwala, Stephanie D. Davis, and Thomas W. Ferkol. Primary ciliary dyskinesia: a clinical review. Cells, 13:974, Jun 2024. URL: https://doi.org/10.3390/cells13110974, doi:10.3390/cells13110974. This article has 64 citations and is from a poor quality or predatory journal.
(weir2025radiantcilia pages 115-118): Madison Weir. Radiant cilia : advancing north american pcd diagnosis with immunofluorescence. Text, Jan 2025. URL: https://doi.org/10.14288/1.0445067, doi:10.14288/1.0445067. This article has 0 citations and is from a peer-reviewed journal.
(carreterovilarroig2025clinicalgeneticmorphological pages 1-2): Lidón Carretero-Vilarroig, Rosana Blanco-Máñez, Noelia Muñoz-Fernández, Isabel Ibáñez, Alba Berzal-Serrano, Ana Reula, Belén García-Bohórquez, Elena Aller, Gema García-García, Jose M. Millán, Miguel Armengot-Carceller, and Teresa Jaijo. Clinical, genetic, morphological and functional correlations in a large series of patients with primary ciliary dyskinesia: a heterogeneous disease with a controversial diagnosis. Molecular diagnosis & therapy, Jul 2025. URL: https://doi.org/10.1007/s40291-025-00801-w, doi:10.1007/s40291-025-00801-w. This article has 0 citations and is from a peer-reviewed journal.